Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	steroid 11-beta-monooxygenase activity	CYP11B1 CYP11B2	5.83e-05	2	153	2	GO:0004507
GeneOntologyMolecularFunction	corticosterone 18-monooxygenase activity	CYP11B1 CYP11B2	5.83e-05	2	153	2	GO:0047783
MousePheno	abnormal pituitary gland size	CYP11B1 CYP11B2 GHR IRS2 MBD5	4.01e-05	42	129	5	MP:0008936
MousePheno	abnormal female reproductive system physiology	NCOA2 CDKN1C ABCA2 KMT2B CYP11B1 CYP11B2 ASH1L RAD21L1 RAD54L2 FAAP100 EZHIP GHR IGF2R CSF1 DGUOK CEP250 ATAD2B KIF19 IRS2 TAF4B CDC25B	4.94e-05	876	129	21	MP:0003699
MousePheno	abnormal urine progesterone level	CYP11B1 CYP11B2	8.45e-05	2	129	2	MP:0011545
MousePheno	abnormal urine deoxycorticosterone level	CYP11B1 CYP11B2	8.45e-05	2	129	2	MP:0011552
MousePheno	decreased urine corticosterone level	CYP11B1 CYP11B2	8.45e-05	2	129	2	MP:0011550
MousePheno	increased urine deoxycorticosterone level	CYP11B1 CYP11B2	8.45e-05	2	129	2	MP:0011553
MousePheno	increased urine progesterone level	CYP11B1 CYP11B2	8.45e-05	2	129	2	MP:0011546
MousePheno	abnormal endometrium morphology	CYP11B1 CYP11B2 ASH1L IGF2R CSF1	8.53e-05	49	129	5	MP:0004896
MousePheno	abnormal female reproductive gland morphology	CDKN1C CYP11B1 CYP11B2 ASH1L RAD21L1 DELE1 FAAP100 EZHIP GHR IGF2R CSF1 CEP250 IRS2 TAF4B	1.24e-04	475	129	14	MP:0013324
MousePheno	increased brain size	CYP11B1 CYP11B2 CSMD3 GHR IGF2R MBD5	1.32e-04	85	129	6	MP:0005238
MousePheno	abnormal pituitary hormone level	C14orf93 CYP11B1 CYP11B2 FAAP100 GHR SLC16A2 IRS2 TAF4B MBD5	1.64e-04	214	129	9	MP:0003965
MousePheno	abnormal brain size	SNPH ATP6V0A1 CYP11B1 CYP11B2 CSMD3 RAX GHR IGF2R RNF10 MBD5 ARHGAP33 HTT	1.81e-04	375	129	12	MP:0000771
MousePheno	increased pituitary hormone level	C14orf93 CYP11B1 CYP11B2 FAAP100 GHR SLC16A2 TAF4B	1.81e-04	128	129	7	MP:0003973
MousePheno	abnormal internal female genitalia morphology	CDKN1C NHSL2 CYP11B1 CYP11B2 ASH1L RAD21L1 DELE1 CR1 FAAP100 EZHIP GHR IGF2R CSF1 CEP250 KIF19 LRP2 IRS2 TAF4B	2.00e-04	757	129	18	MP:0009209
MousePheno	increased placenta weight	CDKN1C GHR IGF2R	2.05e-04	13	129	3	MP:0004920
MousePheno	abnormal female genitalia morphology	CDKN1C NHSL2 CYP11B1 CYP11B2 ASH1L RAD21L1 DELE1 CR1 FAAP100 EZHIP GHR IGF2R CSF1 CEP250 KIF19 LRP2 IRS2 TAF4B	2.20e-04	763	129	18	MP:0009208
MousePheno	abnormal female reproductive system morphology	CDKN1C NHSL2 CYP11B1 CYP11B2 ASH1L RAD21L1 DELE1 CR1 FAAP100 EZHIP GHR IGF2R CSF1 CEP250 KIF19 LRP2 IRS2 TAF4B	2.31e-04	766	129	18	MP:0001119
MousePheno	abnormal paraumbilical vein morphology	PTH1R SETD5	2.52e-04	3	129	2	MP:0013863
MousePheno	enlarged paraumbilical vein	PTH1R SETD5	2.52e-04	3	129	2	MP:0013864
MousePheno	abnormal reflex	TFEB ABCA2 ATP6V0A1 NRL ASH1L KLHDC7B MUC5B GRIN2B CSMD3 USP31 SLC8B1 IGF2R SYT8 SETD5 JMJD6 CEP250 TMEM132A RNF10 NAV2 NID1 FYN HOXB13 NOTCH1 ARHGAP33 HTT	2.86e-04	1294	129	25	MP:0001961
MousePheno	female infertility	CDKN1C CYP11B1 CYP11B2 ASH1L RAD21L1 GHR IGF2R DGUOK KIF19 IRS2 TAF4B CDC25B	4.09e-04	410	129	12	MP:0001926
MousePheno	reduced female fertility	NCOA2 ABCA2 KMT2B RAD21L1 EZHIP IGF2R CSF1 CEP250 ATAD2B IRS2	4.16e-04	296	129	10	MP:0001923
MousePheno	abnormal brain weight	SNPH CYP11B1 CYP11B2 CSMD3 GHR RNF10 MBD5	4.41e-04	148	129	7	MP:0012775
MousePheno	abnormal myocardium layer morphology	ACADVL CYP11B1 CYP11B2 IGF2R SETD5 JMJD6 DGUOK LRP2 MYOCD HCFC1 NOTCH1 NOTCH2	4.46e-04	414	129	12	MP:0005329
MousePheno	vagina atresia	CDKN1C IGF2R LRP2	4.75e-04	17	129	3	MP:0001144
MousePheno	abnormal adrenal gland zona glomerulosa morphology	CYP11B1 CYP11B2	5.01e-04	4	129	2	MP:0008293
MousePheno	decreased urine aldosterone level	CYP11B1 CYP11B2	5.01e-04	4	129	2	MP:0011541
MousePheno	abnormal urine aldosterone level	CYP11B1 CYP11B2	5.01e-04	4	129	2	MP:0011539
MousePheno	abnormal brachiocephalic trunk morphology	SETD5 PRRC2B	5.01e-04	4	129	2	MP:0010663
MousePheno	abnormal urine corticosterone level	CYP11B1 CYP11B2	5.01e-04	4	129	2	MP:0011548
MousePheno	decreased urine hormone level	CYP11B1 CYP11B2	5.01e-04	4	129	2	MP:0014459
MousePheno	abnormal heart layer morphology	ACADVL CYP11B1 CYP11B2 IGF2R SETD5 JMJD6 DGUOK LRP2 MYOCD HCFC1 NOTCH1 NOTCH2	5.29e-04	422	129	12	MP:0010545
MousePheno	increased circulating pituitary hormone level	C14orf93 CYP11B1 CYP11B2 FAAP100 GHR TAF4B	5.38e-04	110	129	6	MP:0005117
MousePheno	decreased mature ovarian follicle number	RAD21L1 GHR CSF1 IRS2 TAF4B	5.63e-04	73	129	5	MP:0002682
MousePheno	vein stenosis	PTH1R SETD5 PAM	5.66e-04	18	129	3	MP:0031477
MousePheno	abnormal ovarian follicle number	CDKN1C RAD21L1 FAAP100 EZHIP GHR CSF1 IRS2 TAF4B	5.86e-04	203	129	8	MP:0008871
MousePheno	enlarged placenta	CDKN1C GHR IGF2R	6.68e-04	19	129	3	MP:0004260
MousePheno	increased fear-related response	ABCA2 SLC9A5 FYN	6.68e-04	19	129	3	MP:0003459
Domain	VWF_type-D	MUC19 MUC5B SUSD2 MUC4	6.93e-06	16	151	4	IPR001846
Domain	VWFD	MUC19 MUC5B SUSD2 MUC4	6.93e-06	16	151	4	PS51233
Domain	VWD	MUC19 MUC5B SUSD2 MUC4	6.93e-06	16	151	4	SM00216
Domain	VWD	MUC19 MUC5B SUSD2 MUC4	6.93e-06	16	151	4	PF00094
Domain	Cyt_P450_mitochondrial	CYP11B1 CYP11B2	6.49e-05	2	151	2	IPR002399
Domain	TIL_dom	MUC19 MUC5B LRP2	1.77e-04	14	151	3	IPR002919
Domain	DUF3454	NOTCH1 NOTCH2	1.94e-04	3	151	2	PF11936
Domain	DUF3454_notch	NOTCH1 NOTCH2	1.94e-04	3	151	2	IPR024600
Domain	DUF3454	NOTCH1 NOTCH2	1.94e-04	3	151	2	SM01334
Domain	Notch	NOTCH1 NOTCH2	3.85e-04	4	151	2	IPR008297
Domain	NODP	NOTCH1 NOTCH2	3.85e-04	4	151	2	PF07684
Domain	Notch_NODP_dom	NOTCH1 NOTCH2	3.85e-04	4	151	2	IPR011656
Domain	AMOP	SUSD2 MUC4	3.85e-04	4	151	2	SM00723
Domain	Shroom_fam	SHROOM4 SHROOM1	3.85e-04	4	151	2	IPR027685
Domain	ASD2_dom	SHROOM4 SHROOM1	3.85e-04	4	151	2	IPR014799
Domain	ASD2	SHROOM4 SHROOM1	3.85e-04	4	151	2	PF08687
Domain	Notch_NOD_dom	NOTCH1 NOTCH2	3.85e-04	4	151	2	IPR010660
Domain	AMOP	SUSD2 MUC4	3.85e-04	4	151	2	PF03782
Domain	NOD	NOTCH1 NOTCH2	3.85e-04	4	151	2	PF06816
Domain	ASD2	SHROOM4 SHROOM1	3.85e-04	4	151	2	PS51307
Domain	AMOP_dom	SUSD2 MUC4	3.85e-04	4	151	2	IPR005533
Domain	AMOP	SUSD2 MUC4	3.85e-04	4	151	2	PS50856
Domain	NOD	NOTCH1 NOTCH2	3.85e-04	4	151	2	SM01338
Domain	NODP	NOTCH1 NOTCH2	3.85e-04	4	151	2	SM01339
Domain	NIDO_dom	NID1 MUC4	6.39e-04	5	151	2	IPR003886
Domain	NIDO	NID1 MUC4	6.39e-04	5	151	2	SM00539
Domain	NIDO	NID1 MUC4	6.39e-04	5	151	2	PF06119
Domain	NIDO	NID1 MUC4	6.39e-04	5	151	2	PS51220
Domain	LNR	NOTCH1 NOTCH2	6.39e-04	5	151	2	PS50258
Domain	SEA	MUC16 MUC12 IMPG2	7.13e-04	22	151	3	PF01390
Domain	SEA	MUC16 MUC12 IMPG2	8.15e-04	23	151	3	PS50024
Domain	SEA_dom	MUC16 MUC12 IMPG2	8.15e-04	23	151	3	IPR000082
Domain	Sushi	CR1 CSMD3 SUSD2 SEZ6	8.22e-04	52	151	4	PF00084
Domain	CCP	CR1 CSMD3 SUSD2 SEZ6	9.48e-04	54	151	4	SM00032
Domain	SUSHI	CR1 CSMD3 SUSD2 SEZ6	1.09e-03	56	151	4	PS50923
Domain	Sushi_SCR_CCP_dom	CR1 CSMD3 SUSD2 SEZ6	1.16e-03	57	151	4	IPR000436
Domain	Notch_dom	NOTCH1 NOTCH2	1.33e-03	7	151	2	IPR000800
Domain	Notch	NOTCH1 NOTCH2	1.33e-03	7	151	2	PF00066
Domain	NL	NOTCH1 NOTCH2	1.33e-03	7	151	2	SM00004
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC16 MUC5B MUC12 SEMA5B MUC4 NOTCH1 NOTCH2	7.40e-07	68	106	7	M27303
Pathway	REACTOME_DECTIN_2_FAMILY	MUC16 MUC5B MUC12 FYN MUC4	1.27e-06	26	106	5	M27483
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC5B MUC12 MUC4	5.13e-06	16	106	4	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC5B MUC12 MUC4	6.67e-06	17	106	4	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC19 MUC16 MUC5B MUC4	1.64e-05	21	106	4	MM15706
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC5B MUC12 MUC4	2.40e-05	23	106	4	M556
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	MUC16 MUC5B MUC12 SEMA5B MUC4 NOTCH1 NOTCH2	1.01e-04	143	106	7	M27275
Pathway	REACTOME_DISEASES_OF_METABOLISM	CYP11B1 CYP11B2 MUC16 MUC5B MUC12 SEMA5B MUC4 NOTCH1 NOTCH2	1.10e-04	250	106	9	M27554
Pathway	REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS	GRIN2B GPRIN1 NOTCH1	3.11e-04	18	106	3	M27901
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TFEB CRYBG2 ABCA2 HIVEP2 KMT2B SIPA1L3 UBR4 FBRSL1 MIB2 PIGG FAAP100 CCDC88C SLC8B1 IGF2R EIF4ENIF1 DNAJC14 SETD5 TMEM132A NAV2 TNKS1BP1 IRS2 LRRC14 MBD5 HCFC1 HOXB13 NOTCH1 RIC1 NOTCH2 ARHGAP33 PRRC2B HTT	2.62e-16	1105	156	31	35748872
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TFEB KIF13B HIVEP2 SIPA1L3 DENND4C RUSC2 NUAK2 USP31 CCDC88C ESYT2 STARD9 RNF10 NAV2 FOXO4 TNKS1BP1 IRS2 CDC25B SRRM2 SH3RF3 NOTCH2	2.14e-09	861	156	20	36931259
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TNIK SNPH SPOCK2 CSMD3 RUSC2 USP31 SETD5 JMJD6 STARD9 NAV3 ASXL2 SRRM2 PRRC2B PDZD2	5.11e-09	407	156	14	12693553
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC19 MUC16 MUC5B MUC12 MUC4	1.39e-08	18	156	5	18834073
Pubmed	Notch1 and Notch2 Coordinately Regulate Stem Cell Function in the Quiescent and Activated States of Muscle Satellite Cells.	PAX7 NOTCH1 NOTCH2	8.85e-08	3	156	3	29139178
Pubmed	High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men.	NCOA2 CDKN1C CYP11B1 PTH1R GHR IGF2R CSF1 GLI2 PAX7 NOTCH1 NOTCH2	1.40e-06	383	156	11	19453261
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC19 MUC16 MUC5B	1.75e-06	6	156	3	19110483
Pubmed	Two miRNA clusters, miR-34b/c and miR-449, are essential for normal brain development, motile ciliogenesis, and spermatogenesis.	KMT2B TAF4B NOTCH1 CNTN2 NOTCH2	4.11e-06	53	156	5	24982181
Pubmed	Construction of a multi-functional cDNA library specific for mouse pancreatic islets and its application to microarray.	NCOA2 CRYBG2 FBRSL1 NDUFS8 SLC8B1 IGF2R JMJD6 ASXL2 MUC4 PRRC2B	7.46e-06	371	156	10	15747579
Pubmed	Expression of Foxm1 transcription factor in cardiomyocytes is required for myocardial development.	MYOCD CDC25B NOTCH1 NOTCH2	1.12e-05	31	156	4	21779394
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	FLG ACADVL UBR4 ASH1L ACAD10 ESYT2 RNF10 ASXL2 LRRC14 TAF4B MBD5 PRRC2B SEZ6	1.51e-05	689	156	13	36543142
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	PCDHB6 ALDH1L1 GPRIN1 KIF19 NAV2 NID1 IRS2 MUC4 SH3RF3 HCFC1 RIC1	1.65e-05	497	156	11	36774506
Pubmed	Antagonistic regulation of p57kip2 by Hes/Hey downstream of Notch signaling and muscle regulatory factors regulates skeletal muscle growth arrest.	CDKN1C PAX7 NOTCH1	1.89e-05	12	156	3	25005473
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	NCOA2 ABCA2 ATP6V0A1 HIVEP2 SIPA1L3 UBR4 ASH1L SPOCK2 GRIN2B RAD54L2 ZNF251 DNAJC14 FAM218A RNF10 NAV3 LRP2 RNF111 SOS2	2.00e-05	1285	156	18	35914814
Pubmed	Common polymorphisms in the CYP11B1 and CYP11B2 genes: evidence for a digenic influence on hypertension.	CYP11B1 CYP11B2	2.00e-05	2	156	2	23150505
Pubmed	GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism.	CYP11B1 CYP11B2	2.00e-05	2	156	2	35012455
Pubmed	Notch1 and Notch2 expression in osteoblast precursors regulates femoral microarchitecture.	NOTCH1 NOTCH2	2.00e-05	2	156	2	24508387
Pubmed	Role of genetic variation in regulation of aldosterone biosynthesis.	CYP11B1 CYP11B2	2.00e-05	2	156	2	21164264
Pubmed	Notch controls generation and function of human effector CD8+ T cells.	NOTCH1 NOTCH2	2.00e-05	2	156	2	23380742
Pubmed	Activated Notch2 signaling inhibits differentiation of cerebellar granule neuron precursors by maintaining proliferation.	CNTN2 NOTCH2	2.00e-05	2	156	2	11545715
Pubmed	Differential Notch1 and Notch2 expression and frequent activation of Notch signaling in gastric cancers.	NOTCH1 NOTCH2	2.00e-05	2	156	2	21466361
Pubmed	The hamster adrenal cytochrome P450C11 has equipotent 11beta-hydroxylase and 19-hydroxylase activities, but no aldosterone synthase activity.	CYP11B1 CYP11B2	2.00e-05	2	156	2	8645611
Pubmed	Notch signaling regulates formation of the three-dimensional architecture of intrahepatic bile ducts in mice.	NOTCH1 NOTCH2	2.00e-05	2	156	2	20069650
Pubmed	Testosterone influenced the expression of Notch1, Notch2 and Jagged1 induced by lipopolysaccharide in macrophages.	NOTCH1 NOTCH2	2.00e-05	2	156	2	15625786
Pubmed	Expression and localization of cytochrome P450(11beta,aldo) mRNA in the frog brain.	CYP11B1 CYP11B2	2.00e-05	2	156	2	12231255
Pubmed	A de novo unequal cross-over mutation between CYP11B1 and CYP11B2 genes causes familial hyperaldosteronism type I.	CYP11B1 CYP11B2	2.00e-05	2	156	2	20634641
Pubmed	Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase.	CYP11B1 CYP11B2	2.00e-05	2	156	2	1303253
Pubmed	Brain-derived neurotrophic factor rapidly increases NMDA receptor channel activity through Fyn-mediated phosphorylation.	GRIN2B FYN	2.00e-05	2	156	2	17045972
Pubmed	Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation.	NOTCH1 NOTCH2	2.00e-05	2	156	2	17261636
Pubmed	Motch A and motch B--two mouse Notch homologues coexpressed in a wide variety of tissues.	NOTCH1 NOTCH2	2.00e-05	2	156	2	8440332
Pubmed	Enhanced striatal NR2B-containing N-methyl-D-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease.	GRIN2B HTT	2.00e-05	2	156	2	15240759
Pubmed	Role of steroid 11 beta-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans.	CYP11B1 CYP11B2	2.00e-05	2	156	2	1741400
Pubmed	Effects of intron conversion in the human CYP11B2 gene on its transcription and blood pressure regulation in transgenic mice.	CYP11B1 CYP11B2	2.00e-05	2	156	2	32540969
Pubmed	Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice.	CYP11B1 CYP11B2	2.00e-05	2	156	2	26047574
Pubmed	Differential expression of Notch1 and Notch2 in developing and adult mouse brain.	NOTCH1 NOTCH2	2.00e-05	2	156	2	7609614
Pubmed	Notch dimerization and gene dosage are important for normal heart development, intestinal stem cell maintenance, and splenic marginal zone B-cell homeostasis during mite infestation.	NOTCH1 NOTCH2	2.00e-05	2	156	2	33017398
Pubmed	Aldosterone synthase knockout mouse as a model for sodium-induced endothelial sodium channel up-regulation in vascular endothelium.	CYP11B1 CYP11B2	2.00e-05	2	156	2	26324851
Pubmed	Microsatellite polymorphism analysis allows the individual assignment of the rat 11 beta-hydroxylase gene (Cyp11b1) and the rat aldosterone synthase gene (Cyp11b2) to chromosome 7 using rat x mouse somatic cell hybrids and identifies differences between and within various rat strains.	CYP11B1 CYP11B2	2.00e-05	2	156	2	7669222
Pubmed	Notch2 governs the rate of generation of mouse long- and short-term repopulating stem cells.	NOTCH1 NOTCH2	2.00e-05	2	156	2	21285514
Pubmed	E3 ubiquitin-protein ligase 2 inhibits cell proliferation, migration, and invasion of non-small cell lung cancer through ubiquitination of Notch1.	MIB2 NOTCH1	2.00e-05	2	156	2	34971948
Pubmed	Both Notch1 and Notch2 contribute to the regulation of melanocyte homeostasis.	NOTCH1 NOTCH2	2.00e-05	2	156	2	18353145
Pubmed	Aldosterone-dependent and -independent regulation of the epithelial sodium channel (ENaC) in mouse distal nephron.	CYP11B1 CYP11B2	2.00e-05	2	156	2	22933298
Pubmed	Notch signal suppresses Toll-like receptor-triggered inflammatory responses in macrophages by inhibiting extracellular signal-regulated kinase 1/2-mediated nuclear factor κB activation.	NOTCH1 NOTCH2	2.00e-05	2	156	2	22205705
Pubmed	Fyn stimulates the progression of pancreatic cancer via Fyn-GluN2b-AKT axis.	GRIN2B FYN	2.00e-05	2	156	2	31957823
Pubmed	Notch signaling induces cell cycle arrest in small cell lung cancer cells.	NOTCH1 NOTCH2	2.00e-05	2	156	2	11306509
Pubmed	Structural and functional analysis of the promoter region of the gene encoding mouse steroid 11 beta-hydroxylase.	CYP11B1 CYP11B2	2.00e-05	2	156	2	2783417
Pubmed	Correlation of asymmetric Notch2 expression and mouse incisor rotation.	NOTCH1 NOTCH2	2.00e-05	2	156	2	10704869
Pubmed	Notch signaling is necessary but not sufficient for differentiation of dendritic cells.	NOTCH1 NOTCH2	2.00e-05	2	156	2	12907456
Pubmed	Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism.	CYP11B1 CYP11B2	2.00e-05	2	156	2	2256920
Pubmed	Inflammatory cytokines induce NOTCH signaling in nucleus pulposus cells: implications in intervertebral disc degeneration.	NOTCH1 NOTCH2	2.00e-05	2	156	2	23589286
Pubmed	Association of DNA polymorphisms within the CYP11B2/CYP11B1 locus and postoperative hypertension risk in the patients with aldosterone-producing adenomas.	CYP11B1 CYP11B2	2.00e-05	2	156	2	20708777
Pubmed	Inhibition of granulocytic differentiation by mNotch1.	NOTCH1 NOTCH2	2.00e-05	2	156	2	8917536
Pubmed	Molecular genetic studies on the biosynthesis of aldosterone in humans.	CYP11B1 CYP11B2	2.00e-05	2	156	2	22217843
Pubmed	Mechanistic study of polychlorinated biphenyl 126-induced CYP11B1 and CYP11B2 up-regulation.	CYP11B1 CYP11B2	2.00e-05	2	156	2	16396990
Pubmed	Functional conservation of Notch1 and Notch2 intracellular domains.	NOTCH1 NOTCH2	2.00e-05	2	156	2	15897231
Pubmed	Increased surface expression of NOTCH on memory T cells in peripheral blood from patients with asthma.	NOTCH1 NOTCH2	2.00e-05	2	156	2	30296524
Pubmed	Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells.	NOTCH1 NOTCH2	2.00e-05	2	156	2	12753746
Pubmed	[123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes.	CYP11B1 CYP11B2	2.00e-05	2	156	2	18397978
Pubmed	Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2.	CYP11B1 CYP11B2	2.00e-05	2	156	2	1518866
Pubmed	Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL.	NOTCH1 NOTCH2	2.00e-05	2	156	2	26041884
Pubmed	Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.	MUC16 MUC4	2.00e-05	2	156	2	23544943
Pubmed	Procollagen I-expressing renin cell precursors.	CYP11B1 CYP11B2	2.00e-05	2	156	2	23761669
Pubmed	GHR and IGF2R genes may contribute to normal variations in craniofacial dimensions: Insights from an admixed population.	GHR IGF2R	2.00e-05	2	156	2	33008707
Pubmed	Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta).	CYP11B1 CYP11B2	2.00e-05	2	156	2	2592361
Pubmed	The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer.	NOTCH1 NOTCH2	2.00e-05	2	156	2	15492845
Pubmed	Unravelling disparate roles of NOTCH in bladder cancer.	NOTCH1 NOTCH2	2.00e-05	2	156	2	29643502
Pubmed	Expression of mucins in mucoid otitis media.	MUC5B MUC4	2.00e-05	2	156	2	14690056
Pubmed	Aldosterone deficiency prevents high-fat-feeding-induced hyperglycaemia and adipocyte dysfunction in mice.	CYP11B1 CYP11B2	2.00e-05	2	156	2	23314847
Pubmed	Effect of variation in CYP11B1 and CYP11B2 on corticosteroid phenotype and hypothalamic-pituitary-adrenal axis activity in hypertensive and normotensive subjects.	CYP11B1 CYP11B2	2.00e-05	2	156	2	17980006
Pubmed	Association between aldosterone production and variation in the 11beta-hydroxylase (CYP11B1) gene.	CYP11B1 CYP11B2	2.00e-05	2	156	2	16984984
Pubmed	Evidence for local aldosterone synthesis in the large intestine of the mouse.	CYP11B1 CYP11B2	2.00e-05	2	156	2	35288482
Pubmed	Homeostatic responses in the adrenal cortex to the absence of aldosterone in mice.	CYP11B1 CYP11B2	2.00e-05	2	156	2	15731365
Pubmed	Mutant Huntingtin Impairs Pancreatic β-cells by Recruiting IRS-2 and Disturbing the PI3K/AKT/FoxO1 Signaling Pathway in Huntington's Disease.	IRS2 HTT	2.00e-05	2	156	2	34331233
Pubmed	Notch Inhibition Prevents Differentiation of Human Limbal Stem/Progenitor Cells in vitro.	NOTCH1 NOTCH2	2.00e-05	2	156	2	31316119
Pubmed	A role for notch signaling in human corneal epithelial cell differentiation and proliferation.	NOTCH1 NOTCH2	2.00e-05	2	156	2	17652726
Pubmed	Phenotypic consequences of variation across the aldosterone synthase and 11-beta hydroxylase locus in a hypertensive cohort: data from the MRC BRIGHT Study.	CYP11B1 CYP11B2	2.00e-05	2	156	2	17651452
Pubmed	Expression of CYP11B1 and CYP11B2 in adrenal adenoma correlates with clinical characteristics of primary aldosteronism.	CYP11B1 CYP11B2	2.00e-05	2	156	2	34743356
Pubmed	Clinical role of Notch signaling pathway in intraductal papillary mucinous neoplasm of the pancreas.	NOTCH1 NOTCH2	2.00e-05	2	156	2	25041344
Pubmed	Polymorphisms in CYP11B2 and CYP11B1 genes associated with primary hyperaldosteronism.	CYP11B1 CYP11B2	2.00e-05	2	156	2	20339375
Pubmed	Endothelium and NOTCH specify and amplify aorta-gonad-mesonephros-derived hematopoietic stem cells.	NOTCH1 NOTCH2	2.00e-05	2	156	2	25866967
Pubmed	Xylosyl Extension of O-Glucose Glycans on the Extracellular Domain of NOTCH1 and NOTCH2 Regulates Notch Cell Surface Trafficking.	NOTCH1 NOTCH2	2.00e-05	2	156	2	32423029
Pubmed	Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism.	CYP11B1 CYP11B2	2.00e-05	2	156	2	20808686
Pubmed	Notch2 signaling is required for potent antitumor immunity in vivo.	NOTCH1 NOTCH2	2.00e-05	2	156	2	20351182
Pubmed	Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets.	CYP11B1 CYP11B2	2.00e-05	2	156	2	21519965
Pubmed	Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children.	CYP11B1 CYP11B2	2.00e-05	2	156	2	21625068
Pubmed	Involvement of Notch in activation and effector functions of γδ T cells.	NOTCH1 NOTCH2	2.00e-05	2	156	2	24489102
Pubmed	Genetic screening for glucocorticoid-remediable aldosteronism (GRA): experience of three clinical centres in Poland.	CYP11B1 CYP11B2	2.00e-05	2	156	2	16110193
Pubmed	Chimeric CYP11B2/CYP11B1 causing 11β-hydroxylase deficiency in Chinese patients with congenital adrenal hyperplasia.	CYP11B1 CYP11B2	2.00e-05	2	156	2	26066897
Pubmed	The Notch pathway in podocytes plays a role in the development of glomerular disease.	NOTCH1 NOTCH2	2.00e-05	2	156	2	18311147
Pubmed	Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours.	NOTCH1 NOTCH2	2.00e-05	2	156	2	25141821
Pubmed	Fyn Kinase regulates GluN2B subunit-dominant NMDA receptors in human induced pluripotent stem cell-derived neurons.	GRIN2B FYN	2.00e-05	2	156	2	27040756
Pubmed	Intraspecific mating with CzechII/Ei mice rescue lethality associated with loss of function mutations of the imprinted genes, Igf2r and Cdkn1c.	CDKN1C IGF2R	2.00e-05	2	156	2	15475262
Pubmed	Cytotoxicity and decreased corticosterone production in adrenocortical Y-1 cells by 3-methylsulfonyl-DDE and structurally related molecules.	CYP11B1 CYP11B2	2.00e-05	2	156	2	18651133
Pubmed	A new presentation of the chimeric CYP11B1/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern.	CYP11B1 CYP11B2	2.00e-05	2	156	2	22083159
Pubmed	In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease.	GRIN2B HTT	2.00e-05	2	156	2	19279257
Pubmed	Notch1 and Notch2 receptors regulate mouse and human gastric antral epithelial cell homoeostasis.	NOTCH1 NOTCH2	2.00e-05	2	156	2	26933171
Pubmed	A role for Notch signaling in trophoblast endovascular invasion and in the pathogenesis of pre-eclampsia.	NOTCH1 NOTCH2	2.00e-05	2	156	2	21693515
Pubmed	Editorial: polymorphisms in CYP11B genes and 11-hydroxylase activity.	CYP11B1 CYP11B2	2.00e-05	2	156	2	15699546
Pubmed	Cyp11b1 is induced in the murine gonad by luteinizing hormone/human chorionic gonadotropin and involved in the production of 11-ketotestosterone, a major fish androgen: conservation and evolution of the androgen metabolic pathway.	CYP11B1 CYP11B2	2.00e-05	2	156	2	18162527
Pubmed	Chronic activation of adrenal Gq signaling induces Cyp11b2 expression in the zona fasciculata and hyperaldosteronism.	CYP11B1 CYP11B2	2.00e-05	2	156	2	38341019
Interaction	YWHAH interactions	NCOA2 TFEB KIF13B ABCA2 HIVEP2 NHSL2 SIPA1L3 TNS2 RNF115 PTH1R DENND4C RUSC2 NUAK2 USP31 CCDC88C ESYT2 SHROOM1 STARD9 RNF10 NAV2 FOXO4 TNKS1BP1 IRS2 CDC25B SRRM2 SH3RF3 NOTCH2 HTT	1.35e-08	1102	152	28	int:YWHAH
Interaction	TOP3B interactions	TFEB CRYBG2 ABCA2 HIVEP2 KMT2B SIPA1L3 UBR4 FBRSL1 MIB2 PIGG FAAP100 CCDC88C SLC8B1 IGF2R EIF4ENIF1 DNAJC14 SETD5 TMEM132A NAV2 TNKS1BP1 IRS2 LRRC14 MBD5 HCFC1 HOXB13 NOTCH1 RIC1 NOTCH2 ARHGAP33 PRRC2B HTT	1.43e-07	1470	152	31	int:TOP3B
Interaction	DCLK1 interactions	TNIK KIF13B DENND4C DGUOK LRP2 CDC25B SH3RF3 HTT	5.47e-06	127	152	8	int:DCLK1
Interaction	CNTN1 interactions	DGUOK FYN NOTCH1 CNTN2 NOTCH2 HTT	1.35e-05	69	152	6	int:CNTN1
Interaction	YWHAG interactions	TFEB KIF13B HIVEP2 NHSL2 SIPA1L3 FNDC5 TNS2 RNF115 DENND4C RUSC2 USP31 CCDC88C ESYT2 SHROOM1 STARD9 CEP250 NAV2 FOXO4 IRS2 CDC25B SRRM2 SH3RF3 NOTCH2 HTT	2.12e-05	1248	152	24	int:YWHAG
Interaction	TLE3 interactions	NCOA2 HIVEP2 FBRSL1 PROSER1 SIX4 RAD54L2 GLI2 TNKS1BP1 ASXL2 PAX7 SRRM2 NOTCH1	2.92e-05	376	152	12	int:TLE3
Interaction	EGR2 interactions	NCOA2 HIVEP2 FBRSL1 PROSER1 SIX4 RAD54L2 HCFC1 PRRC2B	4.74e-05	171	152	8	int:EGR2
GeneFamily	CD molecules\|Mucins	MUC19 MUC16 MUC5B MUC12 MUC4	8.44e-08	21	99	5	648
GeneFamily	Cytochrome P450 family 11	CYP11B1 CYP11B2	8.87e-05	3	99	2	1007
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CR1 CSMD3 SUSD2 SEZ6	2.67e-04	57	99	4	1179
GeneFamily	Acyl-CoA dehydrogenase family	ACADVL ACAD10	1.58e-03	11	99	2	974
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF13B STARD9 KIF19	2.04e-03	46	99	3	622
GeneFamily	Synaptotagmins	SYT16 SYT8	3.83e-03	17	99	2	765
Coexpression	GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_UP	TNIK HIVEP2 SPOCK2 SLC8B1 CD6 ZNF764 SKAP1 CDC25B FYN	3.19e-06	199	156	9	M3084
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	CDKN1C HIVEP2 SPOCK2 CR1 PTH1R GHR PAM MBD5 FYN	5.34e-06	212	156	9	M39221
Coexpression	BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP	HIVEP2 KLHDC7B SP110 NUAK2 CSF1 NAV3 LRP2 NAV2 IRS2 MUC4 PDZD2	6.33e-06	339	156	11	M34012
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN	CDKN1C ATP6V0A1 ACADVL UBR4 SPOCK2 RAD54L2 FAAP100 RNF115 NUAK2 TUBGCP6 SLC8B1 LRRC14 SRRM2 HCFC1 NOTCH1 ARHGAP33 ZNF513	2.96e-05	905	156	17	M40865
CoexpressionAtlas	alpha beta T cells, T.4Mem44h62l.Sp, CD4 TCRb CD44hi CD62Llo, Spleen, avg-3	TNIK HIVEP2 RNF19A SPOCK2 DENND4C ESYT2 CD6 SUSD2 SKAP1 NAV2 CDC25B FYN SNTB2	2.11e-06	359	153	13	GSM538371_500
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d15.VSVOva, CD8+ CD45.1+, Spleen, avg-2	TNIK ABCA2 REXO5 DENND4C CCDC88C ESYT2 IGF2R CD6 SKAP1 CDC25B FYN SNTB2 PRRC2B	2.25e-06	361	153	13	GSM538385_500
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d6.VSVOva, CD8+ CD45.1+, Spleen, avg-3	TNIK REXO5 ZNF251 DENND4C CCDC88C ESYT2 IGF2R CD6 SKAP1 CDC25B FYN SNTB2 PRRC2B	3.31e-06	374	153	13	GSM538389_500
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d8.VSVOva, CD8+ CD45.1+, Spleen, avg-3	TNIK ABCA2 REXO5 DENND4C CCDC88C ESYT2 IGF2R CD6 SKAP1 CDC25B FYN SNTB2 PRRC2B	4.80e-06	387	153	13	GSM538392_500
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d8.LisOva, CD8+ CD45.1+, Spleen, avg-3	TNIK REXO5 DENND4C CCDC88C ESYT2 IGF2R CD6 SKAP1 CDC25B FYN SNTB2 PRRC2B	2.08e-05	380	153	12	GSM605901_500
CoexpressionAtlas	alpha beta T cells, T.8Mem.Sp.OT1.d45.VSVOva, CD8+ CD45.1+, Spleen, avg-3	TNIK ABCA2 REXO5 DENND4C CCDC88C ESYT2 IGF2R CD6 SKAP1 FYN SNTB2 PRRC2B	2.25e-05	383	153	12	GSM538403_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg2+.act.Sp, TCRd+ Vg2+ CD44+, Spleen, avg-3	TNIK ABCA2 SPOCK2 DENND4C ESYT2 IGF2R CD6 SUSD2 SKAP1 NAV2 FYN SNTB2	3.04e-05	395	153	12	GSM476678_500
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d10.LisOva, CD8+ CD45.1+, Spleen, avg-3	TNIK DENND4C CCDC88C ESYT2 IGF2R CD6 SKAP1 CDC25B FYN SNTB2 PRRC2B	7.78e-05	369	153	11	GSM605891_500
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d15.LisOva, CD8+ CD45.1+, Spleen, avg-3	TNIK ABCA2 DENND4C CCDC88C ESYT2 IGF2R CD6 SKAP1 CDC25B FYN SNTB2	9.18e-05	376	153	11	GSM605894_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg2-.Sp.TCRbko, TCRd+ Vg2- CD44-, Spleen, avg-3	TNIK ABCA2 SPOCK2 ESYT2 IGF2R CD6 SUSD2 SKAP1 CDC25B FYN NOTCH1	1.76e-04	405	153	11	GSM605796_500
CoexpressionAtlas	alpha beta T cells, T.4Mem.LN, TCRb CD44high CD122lo CD4, Lymph Node, avg-3	TNIK HIVEP2 RNF19A SPOCK2 ESYT2 CD6 SUSD2 SKAP1 NAV2 FYN	2.22e-04	348	153	10	GSM538362_500
ToppCell	COPD-Lymphoid-T_Regulatory\|World / Disease state, Lineage and Cell class	TNIK NCOA2 RNF19A SPOCK2 CCDC88C FCRL3 SKAP1 PAM FYN	1.55e-08	180	156	9	51a12fbad5fa7bb12e6d616a02ff9b5141e2b063
ToppCell	COPD-Lymphoid-T_Regulatory\|COPD / Disease state, Lineage and Cell class	TNIK NCOA2 RNF19A SPOCK2 CCDC88C FCRL3 SKAP1 PAM FYN	1.96e-08	185	156	9	846403edd4c8f646201d519055198fc38b7ffff9
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	ABCA2 SPOCK2 CCDC88C FCRL3 CD6 SKAP1 CDC25B SRRM2 FYN	3.37e-08	197	156	9	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TNIK MUC16 SBSN SYT16 CSF1 SUSD2 LRP2 FOXO4	1.90e-07	174	156	8	4da79da7a09ee1e345102c5331675ebcdbe56171
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CDKN1C TFEB KIF13B ABCA2 SHROOM4 KIF19 LRP2 CNTN2	2.91e-07	184	156	8	f6d6b3ddada66dae28d3306415bf4efe0934208a
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM MUC5B GRIN2B CSMD3 NAV3 LRP2 MYOCD CNTN2	2.91e-07	184	156	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM MUC5B GRIN2B CSMD3 NAV3 LRP2 MYOCD CNTN2	2.91e-07	184	156	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM MUC5B GRIN2B CSMD3 NAV3 LRP2 MYOCD CNTN2	2.91e-07	184	156	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNIK KIF13B ZBED6 NID1 IRS2 PAX7 SRRM2 SNTB2	3.86e-07	191	156	8	7d1595e616f6f111fc2f5bc1b179c5d67d624cc9
ToppCell	Healthy_donor-CD8+_Tem\|Healthy_donor / disease group, cell group and cell class (v2)	TNIK RNF19A SPOCK2 RNF115 CD6 JMJD6 SKAP1 FYN	4.35e-07	194	156	8	bf2e889de60b2b452a41f4d59a0f2a1865f07184
ToppCell	human_hepatoblastoma-NK.T_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	TNIK SPOCK2 CCDC88C FCRL3 CD6 SKAP1 PAM FYN	4.35e-07	194	156	8	997b02a22d7c89a8fd5615bb79a2a8a34fc3fee6
ToppCell	healthy_donor-Lymphocytic\|healthy_donor / Disease condition, Lineage, Cell class and subclass	TNIK SPOCK2 CCDC88C FCRL3 CD6 SKAP1 CDC25B FYN	5.27e-07	199	156	8	2841e16d54acd344ba454f024e285c28abc37319
ToppCell	Control-Control-Lymphocyte-T/NK-CD8+_Tem\|Control / Disease, condition lineage and cell class	TNIK SPOCK2 CCDC88C CD6 SKAP1 KIF19 CDC25B FYN	5.47e-07	200	156	8	fddb3df5b90eb97ef8ed80fac320c1a90903f012
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NHSL2 GHR STARD9 NAV3 NAV2 NID1 FYN SH3RF3	5.47e-07	200	156	8	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	Children_(3_yrs)-Mesenchymal-chondrocyte-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ALDH1L1 PTH1R GHR SLC9A5 GLI2 TNKS1BP1 CDC25B	1.33e-06	156	156	7	60f1ce38e34b582f589db1e0d6139282c1902b2b
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF13B SNPH BEST3 SPOCK2 DENND4C USP31 MUC4	3.20e-06	178	156	7	fcbbcc44271515de1969b4732b6441c012693d5f
ToppCell	COVID-19-T_cells-Tregs\|COVID-19 / group, cell type (main and fine annotations)	TNIK SPOCK2 CCDC88C FCRL3 CD6 SKAP1 FYN	3.57e-06	181	156	7	534659cf754326c6a73c0daa30e9d610612a0292
ToppCell	facs-Spleen-nan-3m-Lymphocytic-Cd3e_T_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNIK ESYT2 IGF2R CD6 SKAP1 FYN NOTCH1	3.57e-06	181	156	7	be7c7db6b99603759593e6f79cdcaa4bbf234cb7
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CDKN1C MUC16 SBSN SYT16 SUSD2 LRP2 FOXO4	3.70e-06	182	156	7	9966f42c338cbd471efa8ffc765a6ce93693aa75
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CDKN1C TFEB KIF13B ABCA2 SHROOM4 LRP2 CNTN2	3.84e-06	183	156	7	93213124e55d1b673dd345188caf8b5bd31d99fe
ToppCell	facs-Spleen-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNIK ESYT2 IGF2R CD6 SKAP1 FYN NOTCH1	3.98e-06	184	156	7	c37c623c4a5ff1628486d8a6461fa355ad5c264c
ToppCell	IPF-Lymphoid-T_Regulatory\|IPF / Disease state, Lineage and Cell class	TNIK RNF19A SPOCK2 CCDC88C CD6 SKAP1 FYN	4.12e-06	185	156	7	221cbd09d94cc0947d0e3c1aa14716d17cb2068d
ToppCell	human_hepatoblastoma-NK.T_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	SPOCK2 CCDC88C FCRL3 CD6 SKAP1 PAM FYN	4.58e-06	188	156	7	71b7599e7e1d63cc0c8518c0501533755951d58f
ToppCell	Fetal_29-31_weeks-Immune-T_lymphocyte-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TNIK SPOCK2 CCDC88C CD6 SKAP1 TAF4B FYN	4.91e-06	190	156	7	2a8de1cf27a9ebc3825cf9e7a489ecd064dfc7f9
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK KIF13B MGAM SIPA1L3 TACC2 CHPT1 SKAP1	5.08e-06	191	156	7	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPOCK2 TACC2 TSSC4 DENND4C GHR SRRM2 PRRC2B	5.26e-06	192	156	7	1304e69c92cef3bd8c82e3c035a7562f5440139a
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	TNIK RNF19A ASH1L ESYT2 CD6 SKAP1 FYN	5.26e-06	192	156	7	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NHSL2 PTH1R GHR GLI2 NAV3 NAV2 NID1	5.44e-06	193	156	7	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	IPF-Lymphoid\|IPF / Disease state, Lineage and Cell class	RNF19A SPOCK2 CCDC88C FCRL3 CD6 SKAP1 FYN	5.44e-06	193	156	7	bf9d50aea909a28dd1d0933af33842d5f1ae7818
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NHSL2 ALDH1L1 GHR NAV3 NAV2 NID1 IRS2	5.63e-06	194	156	7	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPOCK2 CCDC88C CD6 SKAP1 KIF19 CDC25B FYN	5.63e-06	194	156	7	e72be6dc2711c1d4f16943c8615cf9dc2e961ff3
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SPOCK2 CCDC88C CD6 SKAP1 KIF19 CDC25B FYN	5.63e-06	194	156	7	ac03be73fdc32dacd4a450c0fb28617e043b8444
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SPOCK2 CCDC88C CD6 SKAP1 KIF19 CDC25B FYN	5.63e-06	194	156	7	7ab4418a8a12c488d74af3676bdac672628da80c
ToppCell	CV-Severe-6\|Severe / Virus stimulation, Condition and Cluster	TFEB ACADVL RNF19A SPOCK2 SP110 CD6 FYN	5.63e-06	194	156	7	d33be6ed1de907aeea0c2dce09796556b8efdd4e
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPOCK2 CCDC88C CD6 SKAP1 KIF19 CDC25B FYN	5.63e-06	194	156	7	760761ce7d22edf9a8cec71e8ab0caa273fce3f7
ToppCell	Healthy/Control-CD8+_Tem\|Healthy/Control / Disease group and Cell class	TNIK SPOCK2 RNF115 CD6 JMJD6 SKAP1 FYN	5.82e-06	195	156	7	f4955c176c4918052dc151c5e5249223ec428272
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	NHSL2 PTH1R GHR GLI2 NAV3 NAV2 NID1	5.82e-06	195	156	7	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK MIB2 CCDC88C CD6 SKAP1 KIF19 FYN	5.82e-06	195	156	7	14a6466524c22920daa622fbc710daf1defb46c3
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF13B ASH1L ZBED6 IRS2 PAX7 SRRM2 SNTB2	5.82e-06	195	156	7	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	NHSL2 ALDH1L1 PTH1R GHR NAV3 NAV2 NID1	5.82e-06	195	156	7	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	Healthy_donor-CD8+_Tem\|World / disease group, cell group and cell class (v2)	TNIK RNF19A SPOCK2 RNF115 CD6 SKAP1 FYN	6.02e-06	196	156	7	b04684d319d0c462862677d0f956a389bffef535
ToppCell	healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	SPOCK2 CCDC88C CD6 SKAP1 KIF19 CDC25B FYN	6.02e-06	196	156	7	af00c31612e4fe068e5fccae05368edba46bbd20
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TNIK SPOCK2 CCDC88C CD6 SKAP1 CDC25B FYN	6.02e-06	196	156	7	093fb240e72911dfd360aa6edf8ed2d611c78a1e
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK SPOCK2 CCDC88C CD6 SKAP1 KIF19 CDC25B	6.02e-06	196	156	7	51c750a0fb2b87e17e62b984c91fb16f676d7e76
ToppCell	Influenza_Severe-CD8+_Tem\|Influenza_Severe / Disease group and Cell class	TNIK SPOCK2 CCDC88C CD6 SKAP1 KIF19 CDC25B	6.02e-06	196	156	7	c2d31b2a560309264e846271430a846f09a73ef8
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	TNIK SPOCK2 CCDC88C CD6 SKAP1 CDC25B FYN	6.02e-06	196	156	7	c06caba0c91b8ee66f42bc43ec75eb2475f07056
ToppCell	Healthy/Control-CD8+_Tem\|World / Disease group and Cell class	TNIK RNF19A SPOCK2 RNF115 CD6 SKAP1 FYN	6.02e-06	196	156	7	a6dc92476156a695e15373ea57dc04e30014ac55
ToppCell	severe_COVID-19-CD8+_Tem\|World / disease group, cell group and cell class (v2)	RNF19A SPOCK2 CD6 JMJD6 SKAP1 CDC25B FYN	6.02e-06	196	156	7	f0d3067b0f596dd84da2af4bf062fb9f04ef1dc4
ToppCell	Healthy_donor-CD4+_CTL\|Healthy_donor / disease group, cell group and cell class (v2)	TNIK SPOCK2 RNF115 CCDC88C CD6 SKAP1 KIF19	6.22e-06	197	156	7	48592619b4d6cd1898ed1c2d1d447193efad9efa
ToppCell	10x5'-Lung-Lymphocytic_T_CD8-Tem/emra_CD8\|Lung / Manually curated celltypes from each tissue	SPOCK2 CCDC88C CD6 SKAP1 KIF19 CDC25B FYN	6.22e-06	197	156	7	a573a59e2271f5d0ce5de0b851951ab72659e060
ToppCell	Healthy_donor-CD4+_CTL\|World / disease group, cell group and cell class (v2)	TNIK SPOCK2 RNF115 CCDC88C CD6 SKAP1 KIF19	6.22e-06	197	156	7	1dee9b905ef36e567acc1094a3c0e41f56d1261e
ToppCell	Sepsis-URO-Lymphocyte-T/NK-CD4+_CTL\|URO / Disease, condition lineage and cell class	SPOCK2 CCDC88C CD6 SKAP1 KIF19 PAM CDC25B	6.43e-06	198	156	7	c53405a8d082fbd10131a6ec88b69fdd835f2925
ToppCell	severe_influenza-CD8+_Tem\|severe_influenza / disease group, cell group and cell class (v2)	TNIK SPOCK2 CCDC88C CD6 SKAP1 KIF19 CDC25B	6.43e-06	198	156	7	19d9516a04b75e2c8b6b66b5af25b319b0641ac9
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4\|GI_small-bowel / Manually curated celltypes from each tissue	HIVEP2 RNF19A SPOCK2 CD6 IRS2 FYN PDZD2	6.43e-06	198	156	7	6333e46cd1ccf5841ce15aea98a4b2f5e3ae4675
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK ABCA2 SPOCK2 CCDC88C CD6 SKAP1 KIF19	6.43e-06	198	156	7	a6b942fe850e287e1cb705684e29218072daf891
ToppCell	mild_COVID-19_(asymptomatic)-CD4+_CTL\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	TNIK SPOCK2 RNF115 CD6 SKAP1 KIF19 FYN	6.65e-06	199	156	7	a9b7465ecd9fd7c5ad35970ff7c3c93b4ec2c4c3
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NHSL2 PTH1R GHR NAV3 NAV2 NID1 SH3RF3	6.87e-06	200	156	7	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Influenza-Influenza_Severe-Lymphocyte-T/NK-CD8+_Tem\|Influenza_Severe / Disease, condition lineage and cell class	TNIK SPOCK2 CCDC88C CD6 SKAP1 KIF19 CDC25B	6.87e-06	200	156	7	06d80a7aff4b168b131c80750c335215b0fcff3f
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TNIK SPOCK2 CCDC88C FCRL3 SKAP1 SRRM2 FYN	6.87e-06	200	156	7	109f673a4967ffa52270a0b4f818b3461288db44
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NHSL2 GHR STARD9 NAV3 NAV2 NID1 SH3RF3	6.87e-06	200	156	7	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NHSL2 GHR GLI2 NAV3 NAV2 NID1 SH3RF3	6.87e-06	200	156	7	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Control-Control-Lymphocyte-T/NK-gd_T\|Control / Disease, condition lineage and cell class	TNIK ABCA2 SPOCK2 CD6 SKAP1 KIF19 FYN	6.87e-06	200	156	7	88e502c141bbb73e62aa5830d24bd645376e5f3a
ToppCell	severe-CD8+_Tem\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RNF19A SPOCK2 CD6 SKAP1 KIF19 SRRM2 FYN	6.87e-06	200	156	7	6aa77955017d073a96324e4db6b9950a2ec46cf8
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T\|COVID-19_Severe / Disease, condition lineage and cell class	TNIK SPOCK2 CCDC88C ESYT2 FCRL3 CD6 SKAP1	6.87e-06	200	156	7	f72bc3f6606ae77fe1b0a972e35b3ce0727804d9
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ATP6V0A1 PTCRA POU5F2 MIB2 FAAP100 ZNF764	7.86e-06	134	156	6	0e3f37ef041b751ed45060b5ce39385a2731370b
ToppCell	Adult-Mesenchymal-chondrocyte-D122\|Adult / Lineage, Cell type, age group and donor	TNS2 BCHE ALDH1L1 PTH1R GLI2 NAV2	1.39e-05	148	156	6	81a1e6fdd942a612bf523c59b8b4974f6ca1fdce
ToppCell	Influenza_Severe-CD4+_CTL\|World / Disease group and Cell class	CRYBG2 SPOCK2 CD6 CSF1 SKAP1 KIF19	1.67e-05	153	156	6	0c6c2c6dbc81badd886f125f4e5ba0fb7d52101c
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK SPOCK2 CCDC88C ZBED6 SKAP1 CDC25B	1.74e-05	154	156	6	ec920cae12ea1d14b6c973f6e903f895f80e3c50
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SPOCK2 CD6 EIF4ENIF1 SKAP1 FYN NOTCH1	1.87e-05	156	156	6	fbe23876f0899853cea3c5c4f3044a9cea064d5b
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6\|TCGA-Stomach / Sample_Type by Project: Shred V9	TNIK SIPA1L3 CCDC88C SRRM2 MUC4 HCFC1	2.08e-05	159	156	6	655c0749c238bd68cb797adb83e25a23b8a3cc9d
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MUC19 MUC5B GRIN2B KIAA1549L LRP2 MYOCD	2.15e-05	160	156	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MUC19 MUC5B GRIN2B KIAA1549L LRP2 MYOCD	2.15e-05	160	156	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	URO-Lymphocyte-T_NK-CD4_CTL\|URO / Disease, Lineage and Cell Type	SPOCK2 CCDC88C CD6 SKAP1 KIF19 CDC25B	2.31e-05	162	156	6	1afeeb17e263cf625a4f285203cf82f973735193
ToppCell	T_cells-Tph_and_Tfh\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	TNIK RNF19A SPOCK2 CD6 SKAP1 FYN	2.31e-05	162	156	6	146058f2d60846376078916055d08f68562e3a7c
ToppCell	TCGA-Thymus-Primary_Tumor-Thymoma-Type_C\|TCGA-Thymus / Sample_Type by Project: Shred V9	MUC16 SLC12A8 NUAK2 KIAA1549L TMEM132A MUC4	2.39e-05	163	156	6	2dac87d15051151ccf193760ddd8b82534c3f922
ToppCell	Severe-Lymphoid-NK-CD8_T\|Severe / Condition, Lineage, Cell class and cell subclass	SPOCK2 SBSN FCRL3 STARD9 SKAP1 FYN	2.74e-05	167	156	6	8d41015871616ab7eced5104cd8f70d0efe504f2
ToppCell	droplet-Lung-nan-3m-Lymphocytic-Regulatory_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNIK CRYBG2 CCDC88C CD6 SKAP1 CDC25B	2.83e-05	168	156	6	1df3c8c7a6dceb901805eaba7f86f9943f4f1a9d
ToppCell	droplet-Lung-nan-3m-Lymphocytic-regulatory_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNIK CRYBG2 CCDC88C CD6 SKAP1 CDC25B	2.83e-05	168	156	6	1586451d437b70b2dffe41d782b694702dcaf50b
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK C14orf93 SPOCK2 ZNF764 FAM218A FYN	3.03e-05	170	156	6	adb625124832b0786a590e8f75b61e7263a1e0d4
ToppCell	droplet-Lung-30m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TNIK SLC12A8 CD6 SKAP1 NAV2 TAF4B	3.13e-05	171	156	6	a8adce007ff4c713f71f2359b40cb3575b28c98d
ToppCell	droplet-Kidney-nan-3m-Epithelial-Epcam____proximal_tube_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTH1R GHR CHPT1 SLC16A2 SUSD2 LRP2	3.13e-05	171	156	6	48fc4eca18b102b5ec5050f758281292ee8e10c6
ToppCell	droplet-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTH1R GHR CHPT1 SLC16A2 SUSD2 LRP2	3.13e-05	171	156	6	05fcc72df50a380a913821b5781d9621df37d328
ToppCell	facs-Spleen-nan-24m-Lymphocytic-Cd3e_T_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPOCK2 CD6 SKAP1 NAV2 FYN NOTCH1	3.34e-05	173	156	6	f2eeff86e7dc7f4e3c36f775777d56685d7096cf
ToppCell	facs-Trachea-nan-24m-Mesenchymal-chondrocyte\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDKN1C C14orf93 SPOCK2 SYT8 SLC16A2 PAM	3.34e-05	173	156	6	2226505610af1becc253d0a5550627144ef0ed6b
ToppCell	facs-Spleen-nan-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPOCK2 CD6 SKAP1 NAV2 FYN NOTCH1	3.45e-05	174	156	6	096bc6f1889f2bbadfe1e1a3eb6ae569aaa2ee7d
ToppCell	5'-Adult-Distal_Rectal-Epithelial-goblet-BEST2+_Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MUC5B MUC12 NAV2 IRS2 MUC4 HOXB13	3.56e-05	175	156	6	019ea30ac55748463d7917abf3d3f0e804189bfd
ToppCell	E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TFEB CRYBG2 ABCA2 SPOCK2 ZNF251 SUSD2	3.56e-05	175	156	6	711ace94fa9a763c6ae48171a690953f25deebe4
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NHSL2 SLC12A8 CCDC88C SEMA5B SNTB2 PDZD2	3.68e-05	176	156	6	07abf29d681abdd6c7cc87f9eaf9377e92ce212c
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	BCHE TACC2 CSMD3 SEMA5B ASIC4 SEZ6	3.68e-05	176	156	6	05ec715439f2eb1696f5d8855da0dd1dd70effd0
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CRYBG2 MUC5B SBSN ESYT2 CD6 SUSD2	3.68e-05	176	156	6	91ad2c34144f72283ca112fd3b3784f2f6259f65
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NHSL2 SLC12A8 CCDC88C SEMA5B SNTB2 PDZD2	3.68e-05	176	156	6	c7be4eaa5eb76ad9389fb9d15ad0934e88d267d1
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MGAM ABHD6 ALDH1L1 PTH1R LRP2 PDZD2	3.68e-05	176	156	6	1595dbeee336a81e581325d63208ec6262664ee9
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK SPOCK2 CCDC88C SKAP1 TAF4B FYN	3.80e-05	177	156	6	9edfb50856f5e10672ab194ce0076d6a190e64de
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NHSL2 SLC12A8 CCDC88C SEMA5B SNTB2 PDZD2	3.80e-05	177	156	6	8b003ed7887479c3a010ef37dd981b748256bda7
ToppCell	CV-Severe-7\|Severe / Virus stimulation, Condition and Cluster	KIF13B POU5F2 RNF19A ZBED6 PAM HTT	3.80e-05	177	156	6	82fdd6185b368f54f03de389427cbe3071d21a99
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-BM_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPOCK2 CD6 SUSD2 SKAP1 NAV2 FYN	3.92e-05	178	156	6	888add8935ef3aef9b6693c5698e9d1842e66337
ToppCell	5'-Adult-Distal_Rectal-Epithelial-goblet\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MUC5B MUC12 NAV2 IRS2 MUC4 HOXB13	3.92e-05	178	156	6	9099b47e0756d6a1b7ba1c6aa7b47c5425f649e0
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPOCK2 CD6 SUSD2 SKAP1 NAV2 FYN	3.92e-05	178	156	6	43eda32af2e5e28a92421612d0a4c21e5427a772
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNF19A ODAD1 SPOCK2 CD6 SKAP1 FYN	3.92e-05	178	156	6	a96941fef62c2f4533c557ef825ae3265f8f52db
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NHSL2 SLC12A8 CCDC88C SEMA5B SNTB2 PDZD2	3.92e-05	178	156	6	5d6297f34e104bacefb25c4e2338b50fe13dd19a
Drug	Bicuculline (+) [485-49-4]; Down 200; 10.8uM; PC3; HT_HG-U133A	TNIK CDKN1C C14orf93 KMT2B RNF19A SIPA1L3 ACAD10 SLC9A5 CD6 CSF1 FYN ARHGAP33 SOS2	1.02e-09	196	156	13	4574_DN
Drug	Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; MCF7; HT_HG-U133A	NCOA2 ATP6V0A1 TNS2 SLC12A8 RAD54L2 KLHL22 CSF1 LRP2 HCFC1 ARHGAP33 SOS2	1.20e-07	197	156	11	2228_DN
Drug	alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A	HIVEP2 KMT2B RNF19A DELE1 IGF2R EIF4ENIF1 LRRC14 SRRM2 FYN NOTCH1	1.05e-06	196	156	10	6970_DN
Drug	Homosalate [118-56-9]; Up 200; 15.2uM; PC3; HT_HG-U133A	TFEB CRYBG2 ATP6V0A1 UBR4 SPOCK2 MUC5B ALDH1L1 CD6 CSF1 IMPG2	1.15e-06	198	156	10	3797_UP
Drug	Nilutamide [63612-50-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A	NCOA2 ATP6V0A1 KMT2B PTCRA ACAD10 KLHL22 SLC9A5 CD6 IRS2 HCFC1	1.15e-06	198	156	10	6481_DN
Drug	(+,-)-Octopamine hydrochloride [770-05-8]; Up 200; 21uM; MCF7; HT_HG-U133A	CDKN1C C14orf93 ATP6V0A1 RNF19A SIPA1L3 SPOCK2 GRIN2B CD6 CSF1 CEP250	1.20e-06	199	156	10	6491_UP
Drug	Nialamide [51-12-7]; Down 200; 13.4uM; PC3; HT_HG-U133A	CDKN1C REXO5 KMT2B ASH1L ACAD10 FAAP100 KLHL22 TMEM132A NAV3 SRRM2	1.26e-06	200	156	10	4525_DN
Drug	trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	C14orf93 PTCRA RAD54L2 KLHL22 NUAK2 NAV2 IRS2 TAF4B SOS2	5.93e-06	187	156	9	6984_UP
Drug	Metixene hydrochloride [1553-34-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A	TNS2 SPOCK2 ALDH1L1 KLHL22 RUSC2 SLC9A5 NID1 IRS2 ARHGAP33	7.34e-06	192	156	9	3313_UP
Drug	premix	PTCRA NAV3 PAM CNTN2	7.59e-06	19	156	4	CID000013836
Drug	Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A	KIF13B SLC12A8 RAD54L2 TSSC4 KLHL22 RUSC2 CSF1 SLC16A2 LRRC14	8.32e-06	195	156	9	3525_DN
Drug	Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; PC3; HT_HG-U133A	CDKN1C CRYBG2 PTCRA SPOCK2 KIAA1549L SRRM2 FYN NOTCH2 SOS2	8.67e-06	196	156	9	3703_DN
Drug	Meropenem [96036-03-2]; Down 200; 10.4uM; HL60; HT_HG-U133A	NCOA2 C14orf93 ABHD6 ACAD10 ALDH1L1 SP110 RUSC2 ARHGAP33 SOS2	8.67e-06	196	156	9	6141_DN
Drug	Altretamine [654-05-6]; Down 200; 19uM; HL60; HT_HG-U133A	TFEB CRYBG2 PTCRA CD6 JMJD6 CEP250 FOXO4 LRRC14 SOS2	9.03e-06	197	156	9	3090_DN
Drug	Triamcinolone [124-94-7]; Down 200; 10.2uM; PC3; HT_HG-U133A	KMT2B RNF19A ABHD6 SPOCK2 FAAP100 CSF1 NID1 HCFC1 NOTCH2	9.41e-06	198	156	9	5835_DN
Drug	Oxamniquine [21738-42-1]; Down 200; 14.4uM; MCF7; HT_HG-U133A	KIF13B ABCA2 KREMEN2 SLC12A8 SP110 CCDC88C SLC8B1 LRRC14 SOS2	9.41e-06	198	156	9	7344_DN
Drug	Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A	NCOA2 TFEB KIF13B ABCA2 KREMEN2 ABHD6 ACAD10 CSF1 LRRC14	9.41e-06	198	156	9	6043_DN
Drug	Acetopromazine maleate salt [3598-37-6]; Up 200; 9uM; PC3; HT_HG-U133A	TFEB CD6 CSF1 NAV3 LRP2 FOXO4 FYN HCFC1 IMPG2	9.79e-06	199	156	9	4494_UP
Drug	15(S)-15-methyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A	NCOA2 TFEB CRYBG2 TNS2 FAAP100 KLHL22 RUSC2 CSF1 LRRC14	9.79e-06	199	156	9	7494_DN
Drug	Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; MCF7; HT_HG-U133A	ABCA2 HIVEP2 RNF19A SIPA1L3 SLC12A8 DELE1 KLHL22 CEP250 LRRC14	9.79e-06	199	156	9	7020_DN
Drug	Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; PC3; HT_HG-U133A	CDKN1C HIVEP2 SIPA1L3 TNS2 MUC5B TACC2 DELE1 ZNF764 SOS2	9.79e-06	199	156	9	7148_DN
Drug	Homochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; PC3; HT_HG-U133A	TNIK HIVEP2 KMT2B RNF19A TNS2 CCDC88C NID1 HCFC1 PRRC2B	9.79e-06	199	156	9	7295_DN
Drug	Nifedipine [21829-25-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A	NCOA2 ATP6V0A1 RNF19A KREMEN2 SIPA1L3 SP110 NAV2 IRS2 ARHGAP33	1.02e-05	200	156	9	1692_UP
Drug	Indans	CYP11B1 CYP11B2 BCHE	3.66e-05	10	156	3	ctd:D007189
Drug	IYG	ABHD6 PAM	4.66e-05	2	156	2	CID000447701
Drug	cyadox	CYP11B1 CYP11B2	4.66e-05	2	156	2	ctd:C020728
Drug	18-hydroxydeoxycorticosterone	CYP11B1 CYP11B2	4.66e-05	2	156	2	ctd:C042509
Drug	Naftopidil dihydrochloride [57149-08-3]; Up 200; 8.6uM; HL60; HT_HG-U133A	CRYBG2 ABCA2 ATP6V0A1 PTCRA CD6 CSF1 SRRM2 IMPG2	5.14e-05	190	156	8	2911_UP
Drug	15d-PGJ2; Down 200; 10uM; PC3; HG-U133A	NCOA2 ATP6V0A1 HIVEP2 REXO5 MUC5B DELE1 GRIN2B LRRC14	5.53e-05	192	156	8	446_DN
Drug	Testosterone propionate [57-85-2]; Up 200; 11.6uM; PC3; HT_HG-U133A	NRL PROSER1 ALDH1L1 SLC9A5 CD6 TMEM132A LRP2 NOTCH2	5.74e-05	193	156	8	4676_UP
Drug	Iohexol [66108-95-0]; Up 200; 4.8uM; PC3; HT_HG-U133A	TNIK ACAD10 KLHL22 CSF1 NAV3 HCFC1 ARHGAP33 PRRC2B	5.95e-05	194	156	8	4643_UP
Drug	Altretamine [654-05-6]; Down 200; 19uM; MCF7; HT_HG-U133A	NCOA2 KMT2B SIPA1L3 SLC12A8 CEP250 HCFC1 PRRC2B SOS2	5.95e-05	194	156	8	6467_DN
Drug	Mebeverine hydrochloride [2753-45-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A	NCOA2 ATP6V0A1 SIPA1L3 CCDC88C ZNF764 FYN HCFC1 NOTCH2	5.95e-05	194	156	8	3193_DN
Drug	Nisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; PC3; HT_HG-U133A	TFEB MGAM CRYBG2 CR1 SP110 NUAK2 CCDC88C NAV3	5.95e-05	194	156	8	5091_UP
Drug	Hydrocortisone base [50-23-7]; Up 200; 11uM; MCF7; HT_HG-U133A	CDKN1C CRYBG2 KMT2B ABHD6 MUC5B CR1 SLC9A5 SOS2	5.95e-05	194	156	8	3284_UP
Drug	5707885; Up 200; 50uM; MCF7; HT_HG-U133A	C14orf93 PTCRA NRL SIPA1L3 ALDH1L1 LRP2 ASIC4 FYN	6.17e-05	195	156	8	6433_UP
Drug	Miconazole [22916-47-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A	KIF13B SNPH CR1 RUSC2 CD6 CSF1 NID1 SOS2	6.17e-05	195	156	8	4960_UP
Drug	15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A	KIF13B PTCRA RAD54L2 TSSC4 KLHL22 TMEM132A LRRC14 SOS2	6.17e-05	195	156	8	5228_DN
Drug	Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; PC3; HT_HG-U133A	CDKN1C SIPA1L3 SLC12A8 JMJD6 ZNF764 NAV3 NID1 HTT	6.17e-05	195	156	8	2071_DN
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A	CRYBG2 HIVEP2 RNF19A TNS2 KLHL22 CCDC88C CSF1 SOS2	6.39e-05	196	156	8	3766_DN
Drug	(-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; PC3; HT_HG-U133A	TNS2 SLC12A8 FAAP100 RUSC2 ZNF764 HCFC1 NOTCH2 PRRC2B	6.39e-05	196	156	8	5833_DN
Drug	LY 294002; Up 200; 10uM; HL60; HT_HG-U133A	NCOA2 TFEB PTCRA SLC8B1 SLC9A5 NOTCH1 HTT SOS2	6.39e-05	196	156	8	1168_UP
Drug	Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A	KIF13B ABCA2 SIPA1L3 ABHD6 RAD54L2 LRP2 SRRM2 NOTCH2	6.39e-05	196	156	8	3233_DN
Drug	Pimethixene maleate [13187-06-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A	KIF13B CRYBG2 HIVEP2 SIPA1L3 MUC5B ALDH1L1 KLHL22 IRS2	6.39e-05	196	156	8	7426_UP
Drug	Carbimazole [22232-54-8]; Down 200; 21.4uM; HL60; HT_HG-U133A	NCOA2 KMT2B ACAD10 ALDH1L1 CR1 RUSC2 JMJD6 NOTCH2	6.39e-05	196	156	8	2437_DN
Drug	Cisapride [81098-60-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A	PTCRA ABHD6 RAD54L2 SLC9A5 LRP2 FOXO4 IRS2 SOS2	6.39e-05	196	156	8	3305_UP
Drug	Gemfibrozil [25812-30-0]; Up 200; 16uM; MCF7; HT_HG-U133A	NCOA2 PTCRA SIPA1L3 ASH1L SLC12A8 ZNF764 ARHGAP33 SOS2	6.39e-05	196	156	8	5488_UP
Drug	Estradiol-17 beta [50-28-2]; Up 200; 14.6uM; MCF7; HT_HG-U133A	ATP6V0A1 KMT2B ABHD6 RAD54L2 FAAP100 NAV2 IRS2 SOS2	6.39e-05	196	156	8	5318_UP
Drug	Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; HL60; HT_HG-U133A	NCOA2 KMT2B SIPA1L3 CR1 SP110 FOXO4 HCFC1 SNTB2	6.39e-05	196	156	8	2736_DN
Drug	Deferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A	CDKN1C SIPA1L3 KLHL22 SLC8B1 CSF1 IRS2 HCFC1 SOS2	6.39e-05	196	156	8	3936_DN
Drug	Isosorbide dinitrate [87-33-2]; Down 200; 17uM; MCF7; HT_HG-U133A	ABCA2 KMT2B KREMEN2 ABHD6 RAD54L2 CSF1 HCFC1 SOS2	6.39e-05	196	156	8	6038_DN
Drug	estradiol, USP; Up 200; 0.1uM; MCF7; HT_HG-U133A	KIF13B SIPA1L3 ABHD6 SLC12A8 SP110 GLI2 ZNF764 LRRC14	6.39e-05	196	156	8	6928_UP
Drug	Butoconazole nitrate [32872-77-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A	TFEB PTCRA SIPA1L3 ALDH1L1 KLHL22 CD6 NID1 IMPG2	6.39e-05	196	156	8	5388_UP
Drug	ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A	TOR1AIP2 PTCRA RNF19A NUAK2 IRS2 FYN NOTCH1 PDZD2	6.63e-05	197	156	8	7495_UP
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	KIF13B ABCA2 SIPA1L3 RAD54L2 CSF1 IRS2 ARHGAP33 SOS2	6.63e-05	197	156	8	3886_DN
Drug	Azathioprine [446-86-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A	KIF13B CRYBG2 KMT2B PTCRA SP110 HCFC1 ARHGAP33 SOS2	6.63e-05	197	156	8	1528_UP
Drug	Beta-sistosterol [83-46-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A	KIF13B ABCA2 SIPA1L3 ASH1L SP110 KLHL22 ZNF764 HCFC1	6.63e-05	197	156	8	7332_DN
Drug	Piretanide [55837-27-9]; Up 200; 11uM; MCF7; HT_HG-U133A	TFEB ATP6V0A1 PTCRA NRL CD6 JMJD6 MUC4 ARHGAP33	6.63e-05	197	156	8	3567_UP
Drug	Isopropamide iodide [71-81-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A	C14orf93 TNS2 RAD54L2 SP110 CCDC88C CSF1 NOTCH2 SOS2	6.63e-05	197	156	8	6781_DN
Drug	Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A	TNIK NCOA2 C14orf93 CRYBG2 CEP250 NOTCH2 ARHGAP33 SOS2	6.63e-05	197	156	8	3797_DN
Drug	Aminocaproic acid [60-32-2]; Down 200; 30.4uM; HL60; HT_HG-U133A	KIF13B C14orf93 ATP6V0A1 UBR4 SPOCK2 SLC12A8 DENND4C HCFC1	6.63e-05	197	156	8	3122_DN
Drug	Loxapine succinate [27833-64-3]; Down 200; 9uM; PC3; HT_HG-U133A	TNIK CDKN1C C14orf93 FAAP100 RUSC2 CCDC88C CD6 FYN	6.63e-05	197	156	8	6694_DN
Drug	Oxaprozin [21256-18-8]; Down 200; 13.6uM; PC3; HT_HG-U133A	CDKN1C TFEB C14orf93 REXO5 SIPA1L3 SLC12A8 SLC9A5 ARHGAP33	6.63e-05	197	156	8	3794_DN
Drug	Cefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A	ATP6V0A1 PTCRA PROSER1 MUC5B LRP2 IRS2 SRRM2 ARHGAP33	6.63e-05	197	156	8	3247_UP
Drug	Pentolinium bitartrate [52-62-0]; Up 200; 7.4uM; PC3; HT_HG-U133A	CRYBG2 ABCA2 SIPA1L3 CSF1 JMJD6 FYN NOTCH2 SOS2	6.87e-05	198	156	8	7375_UP
Drug	Streptozotocin [18883-66-4]; Down 200; 15uM; MCF7; HT_HG-U133A	NCOA2 ABCA2 ATP6V0A1 KREMEN2 SLC12A8 LRRC14 FYN SOS2	6.87e-05	198	156	8	7193_DN
Drug	Harmane hydrochloride [21655-84-5]; Down 200; 18.2uM; PC3; HT_HG-U133A	ABCA2 TNS2 RUSC2 NUAK2 GLI2 IRS2 FYN NOTCH2	6.87e-05	198	156	8	4584_DN
Drug	Edrophonium chloride [116-38-1]; Up 200; 19.8uM; MCF7; HT_HG-U133A	NCOA2 TFEB CRYBG2 CR1 IRS2 HCFC1 ARHGAP33 SOS2	6.87e-05	198	156	8	1519_UP
Drug	Oxybenzone [131-57-7]; Down 200; 17.6uM; HL60; HT_HG-U133A	TNIK PTCRA ABHD6 SP110 FAAP100 CEP250 FOXO4 SNTB2	6.87e-05	198	156	8	3092_DN
Drug	Carbimazole [22232-54-8]; Up 200; 21.4uM; HL60; HT_HG-U133A	TNIK CRYBG2 CD6 CSF1 GLI2 FOXO4 NOTCH2 SOS2	6.87e-05	198	156	8	2437_UP
Drug	0225151-0000 [351320-15-5]; Up 200; 10uM; PC3; HT_HG-U133A	TNIK NCOA2 CDKN1C PTCRA RNF19A CSF1 FYN SOS2	6.87e-05	198	156	8	6426_UP
Drug	Sulfasalazine [599-79-1]; Down 200; 10uM; MCF7; HT_HG-U133A	NCOA2 ABCA2 ATP6V0A1 KREMEN2 SIPA1L3 ABHD6 LRP2 IRS2	6.87e-05	198	156	8	2882_DN
Drug	Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A	NCOA2 ABCA2 HIVEP2 KREMEN2 SLC12A8 DELE1 CCDC88C ZNF764	6.87e-05	198	156	8	7169_DN
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A	ATP6V0A1 KREMEN2 SIPA1L3 ABHD6 SLC8B1 GLI2 NAV2 MTRF1L	6.87e-05	198	156	8	6930_UP
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; MCF7; HT_HG-U133A	ATP6V0A1 KREMEN2 ABHD6 SPOCK2 ALDH1L1 RUSC2 SLC9A5 LRP2	6.87e-05	198	156	8	3248_UP
Drug	Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A	KREMEN2 SIPA1L3 TNS2 SLC12A8 IGF2R CEP250 PRRC2B HTT	7.11e-05	199	156	8	7192_DN
Drug	Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; MCF7; HT_HG-U133A	RNF19A SIPA1L3 SLC12A8 KLHL22 CD6 TMEM132A HCFC1 SOS2	7.11e-05	199	156	8	4691_DN
Drug	Tamoxifen citrate [54965-24-1]; Up 200; 7uM; PC3; HT_HG-U133A	TFEB PTCRA KLHL22 GLI2 ZNF764 LRP2 HCFC1 IMPG2	7.11e-05	199	156	8	2050_UP
Drug	Cefaclor [70356-03-5]; Up 200; 10.4uM; HL60; HT_HG-U133A	PTCRA SLC12A8 RUSC2 SLC8B1 CD6 NID1 HCFC1 IMPG2	7.11e-05	199	156	8	2483_UP
Drug	Acetazolamide [59-66-5]; Down 200; 18uM; PC3; HT_HG-U133A	HIVEP2 RAD54L2 SP110 RUSC2 CSF1 IRS2 LRRC14 SRRM2	7.11e-05	199	156	8	1808_DN
Drug	Tyloxapol [25301-02-4]; Up 200; 4uM; MCF7; HT_HG-U133A	CRYBG2 SNPH BCHE SPOCK2 CD6 GLI2 NID1 SRRM2	7.11e-05	199	156	8	6452_UP
Drug	Cyproheptadine hydrochloride [969-33-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A	NCOA2 CDKN1C KIF13B RAD54L2 CSF1 IRS2 TAF4B HCFC1	7.11e-05	199	156	8	1521_UP
Drug	DAPH; Up 200; 10uM; PC3; HG-U133A	ABCA2 KMT2B TNS2 DELE1 SP110 CSF1 PAM PRRC2B	7.11e-05	199	156	8	578_UP
Drug	Cephalothin sodium salt [58-71-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ATP6V0A1 SLC12A8 ALDH1L1 RAD54L2 KLHL22 SLC8B1 CEP250 LRRC14	7.11e-05	199	156	8	6079_DN
Drug	Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; PC3; HT_HG-U133A	KIF13B TNS2 SLC12A8 MUC5B NID1 SRRM2 HCFC1 PDZD2	7.11e-05	199	156	8	7254_DN
Drug	Isopropamide iodide [71-81-8]; Down 200; 8.4uM; PC3; HT_HG-U133A	REXO5 KMT2B RNF19A MUC5B SLC8B1 KIAA1549L LRRC14 SOS2	7.11e-05	199	156	8	7133_DN
Drug	Finasteride [98319-26-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	NCOA2 TFEB ATP6V0A1 KREMEN2 CD6 CSF1 ARHGAP33 SOS2	7.11e-05	199	156	8	6062_DN
Drug	Mephenesin [59-47-2]; Up 200; 22uM; PC3; HT_HG-U133A	CDKN1C PTCRA ACAD10 FAAP100 ZNF764 SKAP1 SRRM2 ARHGAP33	7.11e-05	199	156	8	7374_UP
Drug	Delsoline [509-18-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A	KREMEN2 SLC12A8 ACAD10 ALDH1L1 RAD54L2 SLC8B1 IRS2 LRRC14	7.11e-05	199	156	8	6075_DN
Drug	Diflunisal [22494-42-4]; Up 200; 16uM; PC3; HG-U133A	TNIK SNPH SIPA1L3 ABHD6 IGF2R TAF4B HOXB13 PRRC2B	7.37e-05	200	156	8	1908_UP
Drug	Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; HL60; HT_HG-U133A	TNIK CDKN1C PTCRA SIPA1L3 CSF1 LRP2 FOXO4 HCFC1	7.37e-05	200	156	8	2434_UP
Drug	Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; HL60; HT_HG-U133A	TFEB HIVEP2 PTCRA ABHD6 SPOCK2 FAAP100 CCDC88C CSF1	7.37e-05	200	156	8	1872_DN
Drug	3,4,5,3',4',5'-hexachlorobiphenyl	CYP11B1 CYP11B2 FYN	8.58e-05	13	156	3	ctd:C027309
Drug	1H,1H,2H,2H-perfluorodecanol	NCOA2 CYP11B1 CYP11B2	8.58e-05	13	156	3	ctd:C033729
Drug	dcaB	MGAM ABHD6	1.39e-04	3	156	2	CID000015340
Drug	AC1L1I9D	ABHD6 BCHE	1.39e-04	3	156	2	CID000004478
Drug	18-hydroxycortisol	CYP11B1 CYP11B2	1.39e-04	3	156	2	ctd:C033689
Drug	Thioridazine hydrochloride [130-61-0]; Up 200; 9.8uM; PC3; HT_HG-U133A	CDKN1C TFEB PTCRA SPOCK2 CD6 IRS2 SOS2	2.40e-04	179	156	7	4085_UP
Drug	1,12-dodecanediol	MGAM ABHD6	2.77e-04	4	156	2	CID000079758
Drug	C05489	CYP11B1 CYP11B2	2.77e-04	4	156	2	CID000440708
Disease	cell growth regulator with EF hand domain protein 1 measurement	CYP11B1 CYP11B2 NID1	2.02e-05	11	149	3	EFO_0801461
Disease	Glucocorticoid-remediable aldosteronism	CYP11B1 CYP11B2	2.53e-05	2	149	2	C1260386
Disease	adrenal cortical adenoma (is_marker_for)	CYP11B1 CYP11B2	2.53e-05	2	149	2	DOID:0050891 (is_marker_for)
Disease	X-24422 measurement	IGF2R SCO1	7.57e-05	3	149	2	EFO_0800880
Disease	congenital adrenal hyperplasia (implicated_via_orthology)	CYP11B1 CYP11B2	7.57e-05	3	149	2	DOID:0050811 (implicated_via_orthology)
Disease	transmembrane protein 132A measurement	CD6 TMEM132A	1.51e-04	4	149	2	EFO_0802150
Disease	neurogenic locus notch homolog protein 1 measurement	BCHE NOTCH1	2.51e-04	5	149	2	EFO_0008246
Disease	primary hyperaldosteronism (is_implicated_in)	CYP11B1 CYP11B2	2.51e-04	5	149	2	DOID:446 (is_implicated_in)
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC5B MUC4 NOTCH1	3.14e-04	64	149	4	DOID:4947 (is_marker_for)
Disease	Malignant neoplasm of breast	NCOA2 UBR4 BCHE TACC2 SIX4 SP110 RNF115 KRT76 FCRL3 CSF1 SEMA5B JMJD6 HOXB13 NOTCH1 NOTCH2	3.67e-04	1074	149	15	C0006142
Disease	Conn Syndrome	CYP11B1 CYP11B2	3.75e-04	6	149	2	C1384514
Disease	contactin-2 measurement	NUAK2 CNTN2	3.75e-04	6	149	2	EFO_0008100
Disease	Hyperaldosteronism	CYP11B1 CYP11B2	3.75e-04	6	149	2	C0020428
Disease	colorectal cancer (implicated_via_orthology)	FYN NOTCH1 NOTCH2	4.64e-04	30	149	3	DOID:9256 (implicated_via_orthology)
Disease	Sarcomatoid Renal Cell Carcinoma	DNHD1 BCHE CSMD3 NAV3 MUC4	4.93e-04	128	149	5	C1266043
Disease	Chromophobe Renal Cell Carcinoma	DNHD1 BCHE CSMD3 NAV3 MUC4	4.93e-04	128	149	5	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	DNHD1 BCHE CSMD3 NAV3 MUC4	4.93e-04	128	149	5	C1266044
Disease	Papillary Renal Cell Carcinoma	DNHD1 BCHE CSMD3 NAV3 MUC4	4.93e-04	128	149	5	C1306837
Disease	Renal Cell Carcinoma	DNHD1 BCHE CSMD3 NAV3 MUC4	4.93e-04	128	149	5	C0007134
Disease	protocadherin alpha-7 measurement	CYP11B1 CYP11B2	5.23e-04	7	149	2	EFO_0801973
Disease	adenocarcinoma (implicated_via_orthology)	NOTCH1 NOTCH2	5.23e-04	7	149	2	DOID:299 (implicated_via_orthology)
Disease	central nervous system cancer (implicated_via_orthology)	NOTCH1 NOTCH2	5.23e-04	7	149	2	DOID:3620 (implicated_via_orthology)
Disease	intestinal cancer (implicated_via_orthology)	FYN NOTCH1 NOTCH2	5.62e-04	32	149	3	DOID:10155 (implicated_via_orthology)
Disease	Scoliosis, unspecified	PAX7 NOTCH1	6.95e-04	8	149	2	C0036439
Disease	endometrial cancer (is_marker_for)	CDC25B HOXB13 NOTCH1	7.34e-04	35	149	3	DOID:1380 (is_marker_for)
Disease	amnestic disorder (implicated_via_orthology)	BCHE IRS2	8.91e-04	9	149	2	DOID:10914 (implicated_via_orthology)
Disease	Endomyocardial Fibrosis	FNDC5 IGF2R	8.91e-04	9	149	2	C0553980
Disease	protein FAM163B measurement	CYP11B1 CYP11B2	8.91e-04	9	149	2	EFO_0802936
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	DNHD1 BCHE CSMD3 NAV3 MUC4	9.51e-04	148	149	5	C0279702
Disease	adseverin measurement	CYP11B1 BCHE	1.11e-03	10	149	2	EFO_0801358
Disease	otitis media (is_marker_for)	MUC5B MUC4	1.11e-03	10	149	2	DOID:10754 (is_marker_for)
Disease	androstenedione measurement	CYP11B1 CYP11B2	1.11e-03	10	149	2	EFO_0007972
Disease	uric acid measurement	TNIK SIPA1L3 ABHD6 FBRSL1 ACAD10 RNF115 LRP2 ASXL2 PRRC2B SOS2	1.11e-03	610	149	10	EFO_0004761
Disease	Paroxysmal atrial fibrillation	FBRSL1 BEST3 NAV2 MYOCD MBD5	1.20e-03	156	149	5	C0235480
Disease	prostate cancer (is_marker_for)	NCOA2 KMT2B SETD5 CDC25B HOXB13	1.20e-03	156	149	5	DOID:10283 (is_marker_for)
Disease	familial atrial fibrillation	FBRSL1 BEST3 NAV2 MYOCD MBD5	1.20e-03	156	149	5	C3468561
Disease	Persistent atrial fibrillation	FBRSL1 BEST3 NAV2 MYOCD MBD5	1.20e-03	156	149	5	C2585653
Disease	Parkinson disease	ASH1L FBRSL1 MUC19 MUC12 PAM PAX7 FYN	1.27e-03	321	149	7	MONDO_0005180
Disease	Atrial Fibrillation	FBRSL1 BEST3 NAV2 MYOCD MBD5	1.34e-03	160	149	5	C0004238
Disease	3-hydroxyanthranilate 3,4-dioxygenase measurement	CYP11B1 CYP11B2	1.35e-03	11	149	2	EFO_0021862
Disease	hyperhomocysteinemia (implicated_via_orthology)	BCHE GRIN2B	1.35e-03	11	149	2	DOID:9279 (implicated_via_orthology)
Disease	metabolite measurement, body weight gain	TACC2 KIF19	1.62e-03	12	149	2	EFO_0004566, EFO_0004725
Disease	cholesteryl ester 24:5 measurement	C16orf82 TNS2	1.62e-03	12	149	2	EFO_0021448
Disease	type 2 diabetes mellitus (is_implicated_in)	CYP11B2 BCHE GHR IGF2R IRS2	1.80e-03	171	149	5	DOID:9352 (is_implicated_in)
Disease	fructose measurement	TNIK UBR4	1.90e-03	13	149	2	EFO_0010477
Disease	pre-eclampsia (implicated_via_orthology)	CDKN1C NOTCH2	1.90e-03	13	149	2	DOID:10591 (implicated_via_orthology)
Disease	urate measurement	ASH1L FBRSL1 RNF115 PTH1R LRP2 NID1 PAX7 MBD5 CNTN2 NOTCH2 PRRC2B SOS2	2.01e-03	895	149	12	EFO_0004531
Disease	Neoplasm of uncertain or unknown behavior of bladder	NOTCH1 NOTCH2	2.55e-03	15	149	2	C0496930
Disease	Benign neoplasm of bladder	NOTCH1 NOTCH2	2.55e-03	15	149	2	C0154017
Disease	Carcinoma in situ of bladder	NOTCH1 NOTCH2	2.55e-03	15	149	2	C0154091
Disease	complement factor H-related protein 1 measurement	CYP11B1 CYP11B2 KIAA1549L	2.88e-03	56	149	3	EFO_0600054
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	KMT2B SRRM2	3.28e-03	17	149	2	DOID:0060307 (is_implicated_in)
Disease	Malignant neoplasm of skin	GLI2 NOTCH1 NOTCH2	3.34e-03	59	149	3	C0007114
Disease	Skin Neoplasms	GLI2 NOTCH1 NOTCH2	3.34e-03	59	149	3	C0037286
Disease	Carcinoma of bladder	NOTCH1 NOTCH2	3.67e-03	18	149	2	C0699885
Disease	Prostatic Neoplasms	NCOA2 CYP11B2 ASH1L GHR IGF2R JMJD6 LRP2 MUC4 HOXB13	4.19e-03	616	149	9	C0033578
Disease	Malignant neoplasm of prostate	NCOA2 CYP11B2 ASH1L GHR IGF2R JMJD6 LRP2 MUC4 HOXB13	4.19e-03	616	149	9	C0376358
Disease	cortical thickness	TNIK NCOA2 KMT2B SLC12A8 TACC2 SETD5 NAV3 NAV2 PAM PAX7 SH3RF3 PDZD2 SOS2	4.32e-03	1113	149	13	EFO_0004840

Protein segments in the cluster

Peptide	Gene	Start	Entry
PGHEGTTRSSLDDLS	ABHD6	106	Q9BV23
SLPGFLGSSHTSLGN	BEST3	591	Q8N1M1
GPQGLHDLGRSSSSL	ESYT2	726	A0FGR8
HDLGRSSSSLLASPG	ESYT2	731	A0FGR8
GLHGLSRSSSAPLGL	FBRSL1	331	Q9HCM7
SSSPGRSHSKDRTLG	ASH1L	1746	Q9NR48
SAGAASVSLHLLSPG	BCHE	226	P06276
LSGSHSGESLPLSSG	CSMD3	1831	Q7Z407
SGSTHIFGEPLGAST	ADGRG4	956	Q8IZF6
SPLEGVSSSRGLHAG	DGUOK	21	Q16854
EASPAHTSRGGLVIS	ACAD10	641	Q6JQN1
TGEGRTEATHIGGTS	PAM	291	P19021
SESTHGQTAPSTGGR	FLG	1451	P20930
GALGTGRHTAITLAS	DNHD1	2891	Q96M86
RHVPLGGSVSSASST	RAD54L2	1036	Q9Y4B4
GKGDTSSGPHSRETL	ASXL2	1206	Q76L83
TSGLGRLVSGHISDS	SLC16A2	366	P36021
SGTLGTTHITEPSTG	MUC5B	2776	Q9HC84
GPLIEHSSGSLTGER	RAD21L1	181	Q9H4I0
ESRGSSSHGSIPQGE	RIC1	1376	Q4ADV7
ISPLHGGLDSATSIS	PAX7	406	P23759
SGSRLGGAGSISVSH	KRT76	581	Q01546
GITGLLTAALSGHPS	CD6	6	P30203
EGTAGDSLSLHSGRP	FCN3	216	O75636
GAGGHSTSASLATPI	HCFC1	896	P51610
GSAGHSRISTSAPLS	MUC16	271	Q8WXI7
SGVTLGIAHLPIGTS	MUC16	1641	Q8WXI7
ALGSGSTSISHLPTG	MUC16	3251	Q8WXI7
HLPVTGLSSASTGDT	MUC4	2416	Q99102
VSPGSGSAGSLSRLH	NOTCH2	2231	Q04721
HSGGASLRTLGPSVD	DNAJC14	16	Q6Y2X3
LHPATETGGREATSS	PTCRA	196	Q6ISU1
RSGTGIHIDPLGTSA	JMJD6	181	Q6NYC1
SGHLGRSFLSGEPSQ	NOTCH1	2426	P46531
LSGERGSGQTSHLAP	ATAD2B	771	Q9ULI0
DPGTTGTTHARTTGP	MGAM	61	O43451
GLGSPLGRSRHSSSQ	KIAA1109	4121	Q2LD37
DAGHRSTSTTPGTGL	EZHIP	331	Q86X51
APEALGGRETGSHTL	CCDC88C	1831	Q9P219
RSGLSGFSLQHPGVT	FOXO4	321	P98177
SGGHSTTSPSVRGTE	MUC19	3121	Q7Z5P9
GIAGHSAAVTGITRP	MUC19	5551	Q7Z5P9
HTEATTLTGGRGSIG	MUC19	6316	Q7Z5P9
ISRTSHTGTPAASGG	MUC19	6866	Q7Z5P9
RRSSGSIVSGSLGHP	PDZD2	2371	O15018
DITEPSIGRASLHGG	NID1	996	P14543
SIGRASLHGGEPTTI	NID1	1001	P14543
TSGIPGRGGHRSSTS	NAV3	1146	Q8IVL0
PYTLTGGRHGSVSLL	FAM218A	46	Q96MZ4
RLTSSGPGSGDPSHL	NRL	221	P54845
AGVAHSSAPATTLGL	POU5F2	311	Q8N7G0
SHGLLGSPVRAAASS	CDC25B	36	P30305
RGASAGSLHSPGLSE	KREMEN2	21	Q8NCW0
GLRLQSHPSTDGGLA	GLI2	1006	P10070
RGVHVSGASPESISS	TUBGCP6	381	Q96RT7
SEPTGSGGTLAHTPR	KMT2B	936	Q9UMN6
DLIGIPHLGVSGSST	KIAA1549L	11	Q6ZVL6
HTPTVIASGIGTADG	LRP2	2456	P98164
ASAAARSGTGLTPLH	ANKRD65	131	E5RJM6
ASTSTLHGLGRACGP	ASIC4	46	Q96FT7
SPSGSRVPHDLLGGS	FAAP100	201	Q0VG06
GLGSSRDHVSSTGPA	ODAD1	641	Q96M63
LPSSSGAQGEGHRVS	MYOCD	661	Q8IZQ8
GAQGEGHRVSSPISS	MYOCD	666	Q8IZQ8
VHPILGGALSSGNAS	OLIG3	181	Q7RTU3
PPGGRSLHSSAVAAT	NDUFS8	21	O00217
GSSASLLRGPHPGTS	PROSER1	576	Q86XN7
LSSSTGEAPSRAVGH	KIF19	846	Q2TAC6
RAPLSRSHTLSGGCG	IRS2	396	Q9Y4H2
AGLGALSGSPSHRTS	ARHGAP33	701	O14559
GTRPHSLSLNGGSRE	FAM189B	651	P81408
SSGVSTPGSAGHDII	HTT	481	P42858
VGFGGIHSTPSTVLS	KLHL22	301	Q53GT1
SRSHSSGSVLPLGEL	CSF1	426	P09603
SHLAGTLGLSAGPTS	CARD17	81	Q5XLA6
TLGLSAGPTSGNHLT	CARD17	86	Q5XLA6
LTLGPVSSHSSGDLR	LINC00304	116	Q8N9R0
AILNGRHTGTPSGDI	CR1	1326	P17927
SLTTAAGRPGTGEHV	GHR	571	P10912
QLHSGISGRPAAGTA	CDKN1C	241	P49918
SHTGTLRTRGGTGVT	FYN	71	P06241
EESGPGSTGELRHSL	C14orf93	266	Q9H972
GSTGELRHSLGLTVS	C14orf93	271	Q9H972
RLHSPGATSTAELGS	CEP250	2226	Q9BV73
HPGVGLTSGSSRSLE	CRYBG2	156	Q8N1P7
GERLGLVGHSPSSAS	CYP11B1	206	P15538
LSALVRSSPHGSLGS	DENND4C	1326	Q5VZ89
RSSPHGSLGSVVNSL	DENND4C	1331	Q5VZ89
SAGPGTSGSHLDRST	ABCA2	131	Q9BZC7
TAGLDTSARVSGLHP	CNTN2	866	Q02246
RKPGGLSATGTSSHS	FCRL3	601	Q96P31
GSGPSSSIAIAGTNH	MBD5	841	Q9P267
EDRHGPSSSVGTVIG	KLHDC7B	36	Q96G42
GERLGLVGHSPSSAS	CYP11B2	206	P19099
SSGEGRPVSGHTDTT	GPRIN1	381	Q7Z2K8
AGGGRNLVAHSPLTS	HOXB13	21	Q92826
IGRASPGLHLGSASN	SLC12A8	631	A0AV02
LGGPFSLTTHTGERK	SCO1	136	O75880
HQGGATTTPLASGAS	SBSN	556	Q6UWP8
TSRLPHASSTGNLGL	DELE1	466	Q14154
SHTLSSLATGASGGP	nan	491	A6NNC1
RPSHTLSSLATGASG	nan	761	A6NNC1
TPLHSAISAGTGASG	MIB2	566	Q96AX9
GTRGSSTGAHISPQF	SLC8B1	26	Q6J4K2
PGHLVDVSGTGTLSQ	PCDHB6	731	Q9Y5E3
HSVSTATLSDALGPG	KIF13B	1571	Q9NQT8
PSTGHLFDLSSLSGR	IGF2R	1521	P11717
LFSSLHSTPGGTARS	RUSC2	66	Q8N2Y8
SVGLGSARGTTTTHL	SYT8	86	Q8NBV8
TLHSVGPTAATGGTT	TAF4B	411	Q92750
LTADSSGGSTPDRGH	SUSD2	376	Q9UGT4
ASPGVRAGHVLSSSA	TFEB	121	P19484
GRADAHLGSSSVALP	TOR1AIP2	126	Q8NFQ8
LGGGGSRIDNTTTTH	RNF115	56	Q9Y4L5
GSTSGTLRGHPTPLE	SOS2	1046	Q07890
GLRDGSGTPSRHSLS	SRRM2	1446	Q9UQ35
SGTPSRHSLSGSSPG	SRRM2	1451	Q9UQ35
SSTQSLSHGGAPELL	SYT16	496	Q17RD7
GISLTLSRGTAHPGE	TMEM132A	646	Q24JP5
GEAFVGGRTSSHSPI	NHSL2	1131	Q5HYW2
SLLGGKAPSRHSSSG	NPHP3	1296	Q7Z494
PSELGGLRHASASIG	MTRF1L	171	Q9UGC7
ETSTPEHQGGGLLRS	FNDC5	196	Q8NAU1
LSSGGVPSHNSSTGL	NAV2	1441	Q8IVL1
RASVGSPSSGEGHLA	SIPA1L3	446	O60292
DATPTATKHGTGRGL	SIPA1L3	566	O60292
SENISGSGLHPLASS	SIX4	596	Q9UIU6
TGFPSRSGDGHQTLV	SETD5	956	Q9C0A6
GVNGSVGISRPTSHT	SHROOM1	456	Q2M3G4
TSGGSRRTNGGHLTP	SHROOM4	236	Q9ULL8
DQGGHVLSSTGLTLP	SLC9A5	541	Q14940
SHSATDGSVGLIGVP	STARD9	3071	Q9P2P6
TGLPVASEERTSGSH	IMPG2	496	Q9BZV3
GGSTTPGLERQHSLK	NUAK2	361	Q9H093
GTEETSLHSSFGLGP	SNPH	271	O15079
SLPGGTASSRHGIQK	SP110	296	Q9HB58
SLAGHLLRSPGGSTS	RAX	16	Q9Y2V3
GSGLSLSGLVHPELS	ACADVL	516	P49748
RSGSRSSSLGSTPHE	EIF4ENIF1	346	Q9NRA8
LPGSGSLVGQRLSDH	ALDH1L1	626	O75891
GSTIAGTSVLSPGLH	CHPT1	256	Q8WUD6
SEGHGVSLGSSLASP	NCOA2	541	Q15596
PALGTAGSRAVHTDS	ZNF513	526	Q8N8E2
GTPTEGLGRVSTHSQ	TNIK	941	Q9UKE5
PVDLSNSGIRSHGSG	RNF111	566	Q6ZNA4
ATRSHAGGSSSGLPE	RNF19A	641	Q9NV58
SHTSVTNVGPRVGLG	PTH1R	501	Q03431
GPEVSSLSIHGRAGS	SH3RF3	761	Q8TEJ3
ILLPGTKSTHGSLSG	REXO5	741	Q96IC2
LGPTSTEGHGALSIS	RNF10	656	Q8N5U6
TEGHGALSISPLSRS	RNF10	661	Q8N5U6
ERGSGGLFSPSTAHV	TNKS1BP1	1021	Q9C0C2
VEALSGSVHSGSVPG	TSSC4	281	Q9Y5U2
EGGGRHIISATSLST	PRRC2B	211	Q5JSZ5
GDVTVTSLHPGGSAR	SEZ6	366	Q53EL9
SPDHRDASSIGSVGL	TACC2	41	O95359
LLRSGSTSPHTVSGG	SEMA5B	841	Q9P283
GPSGGEHTPASLTRL	PRR33	271	A8MZF0
ALRRGTEHSGSTVPS	ATP6V0A1	336	Q93050
SVSRGRPGSHLGTST	ZBED6	291	P86452
VHGSSLTADGQIPTG	ZNF251	526	Q9BRH9
SHLSSEGAAPDRGGL	USP31	76	Q70CQ4
GEGHPTSRAGLAAIS	ZFAND2B	136	Q8WV99
GHGSPSTSEVLRGRE	PIGG	636	Q5H8A4
GVPSDSSLGHSSLIS	HIVEP2	1956	P31629
HSGSGCRSPSLGSDL	SNTB2	386	Q13425
TLRTSPADHGGSVGS	UBR4	2881	Q5T4S7
SRLTGPAHSTKQTGG	C16orf82	201	Q7Z2V1
NHSGTLGLSLTSDAP	SKAP1	71	Q86WV1
SVDGSLTHTRGPLDG	TNS2	466	Q63HR2
LGLELTGTRTHGSPD	SPOCK2	361	Q92563
VAGRLSVTLTPGHGD	ZNF764	376	Q96H86
SGLLEASTPVHSSTG	MUC12	386	Q9UKN1
LGRSEESTTVHSSPG	MUC12	3186	Q9UKN1
GLTARLHTSEPGAST	LRRC14	91	Q15048
SAQTLTPILGIHGGS	GRIN2B	116	Q13224